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A B S T R A C T
Background
From previous systematic reviews and meta-analyses there is consensus about the positive effect of exercise training on exercise capacity;
however, the effects on health-related quality of life, mortality and hospital admissions in heart failure remain uncertain.
Objectives
To update the previous systematic review which determined the effectiveness of exercise-based interventions on the mortality, hospi-
talisation admissions, morbidity and health-related quality of life for patients with systolic heart failure.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2007, Issue 4). To update searches
from the previous review, MEDLINE, EMBASE, CINAHL, and PsycINFO were searched (2001 to January 2008). ISI Proceedings
and bibliographies of identified reviews were checked.
Selection criteria
Randomised controlled trials of exercise-based interventions with six months follow up or longer compared to usual medical care or
placebo. The study population comprised adults of all ages (> 18 years) with evidence of chronic systolic heart failure.
Data collection and analysis
All identified references were independently screened by two review authors and those that were clearly ineligible were rejected. Full
papers of potentially relevant trials were obtained. Data were independantly extracted from the included trials and their risk of bias
assessed by a single review author and checked by a second.
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Main results
Nineteen trials (3647 participants) met the inclusion criteria. One large trial recuited 2331 of the participants. There was no significant
difference in pooled mortality between groups in the 13 trials with < 1 year follow up. There was evidence of a non-significant trend
toward a reduction in pooled mortality with exercise in the four trials with > 1 year follow up. A reduction in the hospitalisation rate
was demonstrated with exercise training programmes. Hospitalisations due to systolic heart failure were reduced with exercise and there
was a significant improvement in health-related quality of life (HRQoL). The effect of cardiac exercise training on total mortality and
HRQoL were independent of the degree of left ventricular dysfunction, type of cardiac rehabilitation, dose of exercise intervention,
length of follow up, trial quality, and trial publication date.
Authors’ conclusions
The previous version of this review showed that exercise training improved exercise capacity in the short term in patients with mild to
moderate heart failure when compared to usual care. This updated review provides evidence that in a similar population of patients,
exercise does not increase the risk of all-cause mortality and may reduce heart failure-related hospital admissions. Exercise training may
offer important improvements in patients’ health-related quality of life.
P L A I N L A N G U A G E S U M M A R Y
Exercise based rehabilitation for heart failure
People with heart failure can experience marked reductions in their activities of daily living and health-related quality of life because
of their restricted heart capacity. This can reduce their ability to exercise, which can further reduce fitness making their symptoms
worse. Chronic heart failure is also associated with a substantially increased risk of death. The review found that for people with mild
to moderate systolic heart failure there was neither a reduction or an increase in the risk of death with exercise. However, following
exercise training there was a reduction in hospital admissions due to the systolic heart failure. In both the short and longer term,
exercise training programmes improved health-related quality of life compared to usual care without the exercise. The kinds of exercise
programmes studied varied greatly but were largely aerobic (such as brisk walking). We found no evidence to suggest that exercise
training programmes cause harm.
B A C K G R O U N D
Over the past decade chronic heart failure (CHF) has become
more prevalent worldwide (AHA 2010). This is mainly due to
ageing of the population and the longer survival of people who
have suffered a myocardial infarction with associated heart failure.
Also, the increasing prevalence of obesity and diabetes is likely
to accelerate the incidence of CHF, resulting in high levels of
healthcare utilisation and increasing costs (Campbell 2003).
Both the incidence and prevalence of heart failure increase steeply
with age, with the average age at first diagnosis being 76 years
(Cowie 1999).While around 1 in 35 of people aged 65 to 74 years
has heart failure, this increases to about 1 in 15 for those aged 75
to 84 years and just over 1 in 7 for those aged 85 years and above.
The risk of heart failure is higher in men than in women, in all
age groups, but there are more women thanmen with heart failure
due to population demographics (Campbell 2003).
The prevalence and incidence of CHF is steadily increasing, with
approximately 670,000 new cases annually in the United States
(AHA 2010). Whilst improved management of hypertension has
reduced this condition as an aetiological factor in the development
of CHF, the increased survival rate from myocardial infarction
has led to a subsequent increase in the number of cases of CHF
(Kostis 1997) as has increasing longevity in developed countries.
In the developing world the occurrence of heart failure can often
be attributed to valvular heart disease and nutritional cardiac dis-
ease, such as pellegra, kwashiokor, alcohol induced (Lip 2000).
Estimates of the prevalence of heart failure in the United States
range from 1.2% to 2.2% in middle-aged adults, ages 40 to 59
years; over 80 years of age the prevalence of CHF is in the region
of 12% to 14% (AHA 2009). Heart failure has a poor prognosis as
just under 40% of patients diagnosed with heart failure die within
a year although thereafter the mortality is less than 10% per year
(Cowie 2000). Hospital admission rates for heart failure are ris-
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ing in all industrialised countries particularly among the elderly
(McMurray 2000). Admissions are projected to rise by 50% over
the next 25 years, largely due to the ageing of the population. It
is estimated that the total annual cost of heart failure to the UK
NHS is around £716 million, or around 1.8% of the total UK
NHS budget; approximately 70% of this total is due to the costs of
hospitalisation (NCCCC 2003). The costs increase with disease
severity and the healthcare costs for patients with the most severe
symptoms are between eight and 30 times greater than for those
with mild symptoms (Berry 2001).
Patients with CHF present with a variety of symptoms most of
which are non-specific (Watson 2000). The most frequently pre-
senting symptom is exertional breathlessness. There is no single di-
agnostic test for heart failure and diagnosis relies on clinical judge-
ment based on a combination of history, physical examination,
and appropriate investigations. Other important symptoms are fa-
tigue and lethargy in addition to swelling of the feet and ankles.
The symptoms and functional exercise capacity are used to classify
the severity of heart failure, using the New York Heart Associa-
tion (NYHA) classification (NYHA 1994) and to judge respon-
siveness to treatment. Whilst disease severity is based upon symp-
toms diagnosis is achieved using objective measures, for example
echocardiographic or magnetic resonance assessment of ejection
fraction. The European Task Force report (CHF Taskforce 2001)
proposes that the definition of heart failure should rely on two cri-
teria. These are the symptoms of heart failure at rest or during ex-
ercise (typically breathlessness and fatigue) and objective evidence
of cardiac dysfunction at rest. Where the diagnosis is unclear, a
response to treatment directed towards heart failure may be used
in addition to the above criteria. However, like many chronic dis-
eases, there is a poor correlation between symptoms and the degree
of cardiac impairment and also between symptoms and disease
prognosis (Opasich 2001; van den Brock 1992; van Tol 2006).
In the last decade, a number of evidence based guidelines have
been developed to help improve diagnosis and treatment for pa-
tients with CHF associated with reduced systolic function. These
guidelines cover aetiology, prevention, diagnostic modalities, and
therapeutic interventions (ESC 1995;Hunt 2001; Remme 2001).
Exercise training is now being intensively evaluated for any bene-
fits in the treatment of CHF (Piepoli 1998).
In 2004, the Cochrane systematic review of exercise based inter-
ventions for heart failure was published (Rees 2004a). This review
concluded that exercise training clearly improved short-term (up
to one-year follow up) exercise capacity (see Figure 1; Figure 2;
Figure 3; Figure 4). Of the 29 randomised controlled trials that
were included, only one trial reported on hospitalisations andmor-
tality in the longer term. The other mainly small-scale trials did
not aim to measure clinical events and were of short duration.
Furthermore, a number of included trials did not use validated
health-related quality of life measures. Also in 2004, an individual
patient data meta-analysis by the ExTraMATCH Collaborative
Group (ExTraMatch 2004) concluded that there was no evidence
that supervised exercise training programmes for CHF patients
were dangerous and indeed there was evidence of an overall re-
duction in mortality (hazard ratio: 0.65, 95% confidence interval
0.46 to 0.92). However, the ExTraMATCH study was based on
a limited bibliographic literature search (MEDLINE plus hand-
searching of selected leading cardiac journals), was limited to tri-
als that reported survival data, and included unpublished data. It
has, therefore, been difficult to verify the data and the compre-
hensiveness of the meta-analysis. For example, several of the RCTs
included in the Cochrane review were not included in the ExTra-
MATCH review. In 2006, van Tol and colleagues reported on a
meta-analysis confirming the improvements in exercise capacity
seen in the Cochrane review and also an improvement in qual-
ity of life as assessed by the Minnesota Living with Heart Failure
(MLWHF) questionnaire (van Tol 2006). Most recently, a meta-
analysis by Haykowsky et al demonstrated the benefits of exer-
cise training on cardiac remodelling as measured by ejection frac-
tion, end-diastolic volume, and end-systolic volume (Haykowsky
2007). In summary, to date there is a consensus about the positive
effect of exercise training on exercise capacity however the effects
onmortality, hospital admissions, health-related quality of life and
overall healthcare costs remain uncertain.
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Figure 1. Forest plot of VO2max (m/kg/min) from previous Cochrane review
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Figure 2. Forest plot of exercise capacity in watts from previous Cochrane review
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Figure 3. Forest plot of exercise durations (mins) from previous Cochrane review
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Figure 4. Forest plot of 6 min walk test (metres) from previous Cochrane review
O B J E C T I V E S
To update the previous sytematic review which determined the
effectiveness of exercise based interventions compared with usual
medical care by focusing on the mortality, hospital admission rate,
morbidity and health-related quality of life in patients with heart
failure.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) of either a parallel group or
cross-over design where the follow upwas six months or more after
the start of the intervention.
Types of participants
All adults (≥18 years) with CHF due to ischaemic or non-is-
chaemic cardiomyopathy. Only those studies with criteria for di-
agnosis of systolic heart failure (based on clinical findings and ob-
jective indices such as assessment of ejection fraction) have been
included. Studies including patients with normal systolic function
(for example restrictive cardiomyopathy or hypertensive disease)
were excluded. Where possible, we have distinguished between
patients with primary heart failure (for example dilated cardiomy-
opathy (DCM)) and thosewith heart failure secondary to coronary
heart disease (CHD). Studies that included patients with normal
systolic function but poor diastolic function or who had previously
been offered cardiac rehabilitation for either myocardial infarction
or heart failure were excluded.
Types of interventions
Exercise based interventions either alone or as a component of
comprehensive cardiac rehabilitation (defined as programmes in-
cluding components such as health education and psychological
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interventions in addition to exercise interventions). The compar-
ison group was usual medical care (for example monitoring, drug
therapy, and advice) as defined by the study.
Types of outcome measures
Primary outcomes
Mortality: all-cause death, deaths due to heart failure and sudden
death
Hospital admission or re-hospitalisation, andwhether due toCHF
Secondary outcomes
Health-related quality of life (HRQoL) assessed by a validated
outcome measure (e.g. Short-form 36 (SF-36), Minnesota Living
with Heart Failure (MLWHF) questionnaire)
Healthcare utilisation and costs
Search methods for identification of studies
A generic search strategy was carried out as this review forms one
of a series of reviews that includes updates of three Cochrane
systematic reviews addressing cardiac rehabilitation (Davies 2008;
Jolliffe 2001; Rees 2004a; Rees 2004b; Taylor 2010).
Electronic searches
For the previous review (Rees 2004a) the Cochrane Controlled
Trials Register (The Cochrane Library 2001, Issue 2), MEDLINE
(2000 to March 2001), EMBASE (1998 to March 2001), and
CINAHL (1984 to March 2001) were searched (see Appendix 2).
This searchwas updated by searching theCochrane Central Regis-
ter of Controlled Trials (CENTRAL) (TheCochrane Library 2007,
Issue 4), MEDLINE, EMBASE, CINAHL, and PsycINFO (2001
to January 2008).
Conference Proceedings were searched onWeb of Science: ISI Pro-
ceedings (2001 to April 2008). Additional studies were located in
theNHSCentre forReviews andDissemination (CRD)databases:
Health Technology Assessment (HTA) and Database of Abstracts
of Reviews of Effects (DARE).
Searches were limited to RCTs, systematic reviews, andmeta-anal-
yses; and a filter was applied to limit to humans. No language
or other limitations were imposed. Consideration was given to
variations in terms used and the spelling of terms in different
countries so that studies were not missed by the search strategy.
Search strategies were designed with reference to those of the pre-
vious systematic review (Rees 2004a) and in accordance with the
Cochrane Handbook of Reviews of Interventions (Higgins 2008),
see Appendix 1 for details.
Searching other resources
Reference lists of all eligible trials and identified systematic reviews
were searched for additional studies.
Data collection and analysis
Study selection
The references identified by the search strategy were screened by
title and abstract and clearly irrelevant studies discarded. For selec-
tion, abstracts had to clearly identify the study design, an appro-
priate population, and relevant components of the intervention
as described above. The full-text reports of all potentially relevant
trials were obtained and assessed independently by two review au-
thors (EJD and RST) for eligibility based on the defined inclusion
criteria. Any disagreements were resolved by discussion.
Data extraction
Relevant data regarding inclusion criteria (study design; partici-
pants; interventions including type of exercise, frequency, dura-
tion, intensity, and modality; comparisons; and outcomes), risk of
bias (randomisation, blinding, attrition, and control), and results
were extracted. Data extraction was undertaken independently by
a single review author (EJD) and checked by a second review au-
thor (RST). Study authors were contacted to seek clarification
on issues of reporting or to obtain further outcome details. Ex-
cluded studies and reasons for their exclusion are detailed in the
’Characteristics of excluded studies’ table.
Assessment of risk of bias in included studies
Factors considered included the quality of the random sequence
generation and allocation concealment, incomplete outcome data,
analysis by intention-to-treat, blinding (participants, personnel,
and outcome assessors), and selective outcome reporting (Higgins
2008). The risk of bias in eligible trials was assessed independently
by a single review author (EJD) and verified by a second (RST).
Data analysis
Data were processed in accordance with the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2008). Dichoto-
mous outcomes were expressed as relative risks (RR) and 95%
confidence intervals (CI) calculated for each study. For continu-
ous variables net changes were compared (that is exercise group
minus control group to give differences) and a weighted mean
difference (WMD) or standardised mean difference (SMD) and
95% CI calculated for each study. The Klocek trial had two inter-
vention arms; for the purpose of meta-analysis it was split into two
subtrials (sample size assumed to be 50% of the overall control
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sample size for each substudy) (Klocek 2005 (Low); Klocek 2005
(High)).
Heterogeneity amongst included studieswas explored qualitatively
(by comparing the characteristics of included studies) and quan-
titatively (using the Chi2 test of heterogeneity and the I2 statis-
tic). Where appropriate, the results from included studies were
combined for each outcome to give an overall estimate of treat-
ment effect. A fixed-effect model meta-analysis was used except
where statistical heterogeneity was identified, where a random-ef-
fects model was used.
Univariate meta-regression was used to examine the association
between the effect of exercise on all-cause mortality and health-
related quality of life and specific study covariates: mean left ven-
tricular ejection fraction (%); effect of intensity of the interven-
tion (’dose’ calculated as the number of weeks, multiplied by the
number of sessions per week, multiplied by the duration of ses-
sions in hours); type of exercise (aerobic training alone or aerobic
plus resistance training); age; sex (per cent male); setting (hospital
only, home only, both hospital and home); type of rehabilitation
(exercise only versus comprehensive); duration of follow up; and
publication date. We added year of publication as an additional
study level factor (pre versus post 2000) in order to assess the po-
tential effect of a change in the standard of usual care over time,
that is to reflect when beta-blockers, angiotensin-receptor block-
ers, and angiotensin-converting enzyme inhibitors became estab-
lished therapies for CHF (Shekelle 2003). These subgroups were
defined a priori. Sensitivity analysis was undertaken to examine
the effect of omission of theHF-ACTION trial. Funnels plots and
Egger tests (Egger 1997) were used to assess potential publication
bias.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
The original Cochrane review (Rees 2004a) identified eight trials
that reported outcomes that met the inclusion criteria of this up-
date review (Belardinelli 1999; Gottlieb 1999; Hambrecht 1995;
Hambrecht 1998; Hambrecht 2000; Keteyian 1996; McKelvie
2002; Willenheimer 2000). The remaining trials were excluded
as their follow up was less than six months or they reported only
exercise capacity outcomes. Our update of the umbrella cardiac
rehabilitation electronic search yielded a total 11,561 titles. After
reviewing titles and abstracts, an additional 65 full papers were re-
trieved for possible inclusion. A total of 50 papers were excluded:
19 had follow up less than six months, 21 reported inappropri-
ate outcomes, three were in a non-heart failure population, six
were reviews, and one was a study protocol. The total number
of included RCTs was therefore 19 trials (23 papers). Although
published after completion of the bibliographic searches, the HF-
ACTION trial (HF ACTION 2009) was included as the proto-
col for this study was identified by our searches (Wheelan 2007).
The study selection process is summarised in the QUORUMflow
diagram shown in Figure 5.
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Figure 5. Summary of study selection process
The included 19 trials randomised a total of 3647 heart failure
patients with New York Heart Association (NYHA) class I to IV
and left ventricular ejection fraction (LVEF) < 40%. The majority
of trials were small, ranging from 20 to 200 participants, with only
the one large trial, HF-ACTION, which contributed over 60%
(2331 participants) of all included patients. The mean age of par-
ticipants across the included studies ranged from 43 to 72 years.
Studies recruited predominantly male patients (43% to 100%).
Only four trials reported on ethnicity and 60% to 100% of the
study population was white. Four trials reported follow up in ex-
cess of 12 months (Austin 2005; Belardinelli 1999; HF ACTION
2009; Mueller 2007). One trial had two treatment arms consist-
ing of high and low intensity exercise. These were treated as two
separate trials for the purpose of the analysis (Klocek 2005 (Low),
Klocek 2005 (High)).
All studies evaluated an aerobic intervention and five also included
resistance training. Exercise trainingwas delivered in a centre based
setting in 10 studies, in a home based setting in one study, and
in a mix of both centre and home in the remaining studies. The
dose of exercise training ranged widely across studies with session
duration of 15 to 120 mins, two to seven sessions/week, intensity
of 40% of maximal heart rate to 85% of maximal oxygen uptake
(VO2 max), over a period of 24 to 52 weeks.
Details of the studies included in the review are shown in the
table ’Characteristics of included studies’. Reasons for exclusion
are presented in the table ’Characteristics of excluded studies’.
Risk of bias in included studies
The overall quality of trials was poor. A number of studies failed
to give sufficient detail to assess their potential risk of bias (Figure
6; Figure 7). Details of generation and concealment of random
allocation sequence and if an intention-to-treat analysis was used
were particularly poorly reported.Only the studies of Austin2005,
McKelvie 2002 and the HF ACTION 2009 trial provided an
adequate description of the randomisation process. Nevertheless,
none of the studies had objective evidence of imbalance in baseline
characteristics. Austin 2005, Giannuzzi 2003, Keteyian 1996, and
HF ACTION 2009 stated that they performed an intention-to-
treat analysis. Although often not stated, many studies appeared
to compare exercise and control group outcomes according to the
initial random allocation. Given the nature of an exercise inter-
vention, is not possible to blind patients and care-givers. Only the
studies of McKelvie 2002, Koukouvou 2004 and Willenheimer
2000 reported blinding of outcome assessment. Only the stud-
ies of Giannuzzi 2003, HF ACTION 2009, Passino 2006 and
McKelvie 2002 were multicentre studies. The majority were in
single centres, leading to additional risk of bias.
10Exercise based rehabilitation for heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 6. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 7. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Effects of interventions
Mortality
Thirteen studies reported all-cause mortality at up to 12-months
follow up. The trials of Gielen 2003 and Klecha 2007 reported
no deaths in either the exercise or control arm. There was no
significant difference in pooled mortality between groups (fixed-
effect relative risk (RR) 1.02, 95% CI 0.70 to 1.51; P = 0.90,
I² = 0%; Chi² = 3.89, P = 0.90) (Analysis 1.1). The studies of
Austin 2005, Belardinelli 1999, HF ACTION 2009 and Mueller
2007 reportedmortality at 26, 60, 75, and 30months respectively.
There was evidence of a non-significant trend towards a reduction
in mortality with longer follow up in the three smaller trials and
this remained when the four trials were pooled (fixed-effect RR
0.88, 95% CI 0.73 to 1.07; P = 0.21, I² = 47%; Chi² = 5.69,
P = 0.14) (Analysis 1.2). A significant reduction in longer-term
mortality was seen with exclusion of the HF-ACTION trial (RR
0.62, 95% CI 0.39 to 0.98). It is important to note that there
may be moderate heterogeneity in this observation. Studies did
not consistently report deaths due to heart failure or sudden death.
Hospital admissions
Whilst there was a trend towards a reduction in the number of
patients experiencing hospital admissions with exercise, none of
these reductions achieved statistical significance (at P < 0.05): hos-
pital admissions up to 12-months follow up (fixed-effect RR 0.79,
95% CI 0.58 to 1.07; P = 0.13, I² = 0%; Chi² = 5.07, P = 0.44)
(Analysis 1.3) and hospital admissions > 12-months follow up
(fixed-effect RR 0.96, 95% CI 0.90 to 1.02; P = 0.15, I² = 37%;
Chi² = 4.74, P = 0.19) (Analysis 1.4). This longer-term result was
consistent when the HF-ACTION trial was excluded (RR 0.75,
95% CI 0.52 to 1.08). Heart failure-specific admissions signifi-
cantly reduced with exercise (fixed-effect RR 0.72, 95% CI 0.52
to 0.99; P = 0.04, I² = 16%; Chi² = 7.17, P = 0.31) (Analysis 1.5).
Health-related quality of life
Ten out of the 19 included trials reported a validated health-re-
lated quality of life (HRQoL) measure (see Table 1). The majority
of studies reported disease-specific quality of life using the Min-
nesota Living with Heart Failure questionnaire (MLWHF) or the
recently developed Kansas City Cardiomyopathy Questionnaire
(KCCQ). Generic HRQoL was also assessed using the EuroQoL
(EQ-5D), the Psychological General Wellbeing index (PGWB),
Patient’s Global Assessment of Quality of life (PGAQoL), and
Spritzer’s Quality of Life Index (QLI). The study byGottlieb 1999
reported HRQoL values at follow up for the exercise group but
not the controls. At follow up there was a consistently higher
HRQoL in exercisers versus controls. Across the six studies that
reported the total MLWHF score, there was a significant improve-
ment with exercise (random-effects mean difference (MD) -10.3,
95% CI -15.9 to -4.8; P = 0.0003, I² = 71%; Chi² = 17.15, P
< 0.004) (Analysis 1.6). Pooling across all studies, regardless of
the HRQoL measure used, there was also evidence of a significant
improvement with exercise (using a random-effects model due to
significant heterogeneity, SMD -0.56, 95% CI -0.82 to -0.30; P
< 0.0001, I² = 79%; Chi² = 43.25, P < 0.0001) (Analysis 1.7),
a finding that remained on exclusion of HF-ACTION (SMD -
0.63, 95% CI -0.89 to -0.37). Where studies reported more than
one total HRQoL measure score, we randomly selected a single
score for meta-analaysis to prevent double counting of a study; the
inference of the SMDmeta-analysis did not change when selecting
the alternative HRQoL measure score.
Cost effectiveness
Two studies considered cost effectiveness (Belardinelli 1999; HF
ACTION 2009) but only Belardinelli undertook a comprehen-
sive cost-effectiveness analysis, which was reported in a separate
publication (Georgiou 2001). The 14-month trial survival and
healthcare costs were extrapolated to 15.5 years and the incremen-
tal cost per life year gained ratio for exercisers compared to con-
trol. The estimated increment cost for the training group, USD
3227/patient, was calculated by subtracting the averted hospitali-
sation cost, USD 1336/patient, from the cost of exercise training
and wage lost due to exercise training, estimated at USD 4563/
patient. For patients receiving exercise training, the estimated in-
crement in life expectancy was 1.82 years/person in a time period
of 15.5 years compared with patients in the control group. The
cost-effectiveness ratio for long-term exercise in patients was thus
determined as $1773/life-year saved (at a 3% discount rate, year
1999 costs).
Meta regression
Predictors of all-cause mortality and HRQoL intervention effects
were examined using univariate meta-regression. Covariates de-
fined a priori included mean LVEF (%); effect of intensity of the
intervention (’dose’ calculated as the number of weeks, multiplied
by the number of sessions per week, multiplied by the duration of
sessions in hours); type of exercise (aerobic training alone or aer-
obic plus resistance training); age; sex (% male); setting (hospital
only, home only, both hospital and home); type of rehabilitation
(exercise only versus comprehensive); duration of follow up; and
publication date. No significant associations were seen on all-cause
mortality and HRQoL at the P < 0.01 level (see Table 2). Sensi-
tivity analysis was undertaken to examine the effect of omission
of the HF-ACTION trial.
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Small study bias
Although there was no evidence of funnel plot asymmetry for all-
cause mortality (Egger test P = 0.874) (Figure 8), the funnel plot
for HRQoL did show asymmetry (Egger test P = 0.002) (Figure
9).
Figure 8. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.1 All cause
mortality <12 month follow up.
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Figure 9. Funnel plot of comparison: 1 All exercise interventions versus usual care, outcome: 1.8 Health
related quality of life - all scales.
D I S C U S S I O N
The Cochrane systematic review of exercise based interventions as
published in 2004 concluded that exercise training programmes
improved exercise capacity and health-related quality of life in the
short term (six months or less follow up) (Rees 2004a). However,
of the 29 randomised controlled trials (RCTs) included in that
review, only one trial reported on hospitalisations and mortality
in the longer-term; the remainder were mainly small-scale trials
which did not measure clinical events and were of short duration.
Furthermore, a number of included trials did not use validated
health-related quality of life (HRQoL) measures. Using additional
RCT evidence, available since the original Cochrane review, the
aim of this update was to reassess the effectiveness of exercise based
interventions on mortality, hospitalisation admissions, morbidity,
and HRQoL of patients with chronic systolic heart failure when
compared with usual medical care. We did not seek to update the
evidence on exercise capacity.
Our updated review shows that, when compared to usual care,
exercise training programmes did not significantly impact on all-
cause mortality. We found a significant reduction in hospitali-
sations due to systolic heart failure with exercise training pro-
grammes and observed consistent significantly higher levels of
HRQoL following exercise trainingprogrammes compared to con-
trol. It is important to note that there was signficant heterogeneity
in our observations on HRQoL. On the Minnesota Living with
Heart failure (MLWHF) questionnaire, the exercise group was on
average 10 points higher than controls. A difference of four points
or larger on the MLWHF questionnaire has been shown to rep-
resent a clinically important, meaningful difference for patients
(McAlister 2004). There was no evidence of a difference in the
effect of exercise training programmes according to patient char-
acteristics (age, sex, %LVEF), nature of the exercise programme
(total dose and inclusion of resistance training), or setting (hospi-
tal or home based). The cost-effectiveness ratio for exercise train-
ing in heart failure patients, extrapolated to 15.5 years, was USD
1773/per life year saved at 1999 costs.
Previous systematic reviews of exercise training programmes for
heart failure, including the 2004 Cochrane review, identified in-
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sufficient numbers of deaths and hospital admissions to reliably
comment on these outcomes (Lloyd-Williams 2002; Rees 2004a;
Smart 2004). Based on an individual patient data pooled analysis,
the ExTraMATCHCollaborativeGroup (ExTraMatch 2004) con-
cluded that exercise significantly reduced overall mortality (hazard
ratio 0.65, 95% CI 0.46 to 0.92). However, the ExTraMATCH
studywas based on a limited bibliographic literature search (MED-
LINE plus handsearching of selected leading cardiac journals), was
limited to trials that reported survival data, and included unpub-
lished data. It has therefore been difficult to verify the data and
the comprehensiveness of this meta-analysis; additionally several
of the RCTs included in the Cochrane review were not included
in the ExTraMATCH review. Re-analysis of the ExTraMatch trial
data using meta-analytic methods has shown that the effect of ex-
ercise training was not statistically signficant when compared to
control (relative risk 0.88, 95%CI 0.70 to 1.10) (Gotzsche 2005),
which is consistant with our findings. More recent trials have been
conducted in the context of optimal medical therapy. For exam-
ple, at entry to the HF-ACTION trial 94% of patients were re-
ceiving beta-blockers and angiotension-receptor blockers or an-
giotensin-converting enzyme inhibitors (Wheelan 2007). Forty-
five per cent had an implantable cardioverter defibrillator (ICD)
or implanted biventricular pacemaker at the time of enrolment.
Given the proven survival advantage of these medical treatments
(Shekelle 2003), any incremental all-cause mortality benefit with
exercise is likely to be small. Based on the observed levels of mor-
tality seen in four trials with long-term follow up, a total of some
12,000 patients would need to be randomised to exercise based
cardiac rehabilitation or usual care to demonstrate a statistically
significant benefit of exercise, at 5% alpha and 80% power (Austin
2005; Belardinelli 1999; HF ACTION 2009; Mueller 2007). The
improvements in HRQoL seen with exercise training are in accor-
dancewith the previous systematic reviewof vanTol and colleagues
(van Tol 2006) but not with that of Chien, which focused on three-
months home based exercise training and concluded that exercise
training compared with usual care or activity did not improve the
HRQoL of heart failure patients (Chien 2008). Eight of the trials
included in our review combined an initial period of supervised
hospital exercise training and a following home-based programme
(Austin 2005; Gielen 2003; Hambrecht 1995; Hambrecht 1998;
Hambrecht 2000; HF ACTION 2009; McKelvie 2002; Passino
2006). Only one included study assessed an entirely home based
programme (Gottlieb 1999). We found no difference in the im-
provement inHRQoL with exercise training in those studies based
solely in a hospital setting compared to those that included some
level of home based exercise training programme.
The precise mechanism(s) through which exercise training bene-
fits patients with heart failure remains unclear. One explanation,
applicable to patients with ischaemic causes of heart failure, is
that exercise training improves myocardial perfusion by alleviat-
ing endothelial dysfunction therefore dilating coronary vessels and
by stimulating new vessel formation by way of intermittent is-
chaemia (ExTraMatch 2004). Indeed, Belardinelli and colleagues
have demonstrated that aerobic training improvesmyocardial con-
tractility and diastolic filling (Belardinelli 1998). Ventricular re-
modelling has been shown to be attenuated by exercise training
(Haykowsky 2007). Regardless of cause, there are important neu-
rohormonal and musculoskeletal abnormalities in heart failure.
Exercise training may reduce adrenergic tone and increase vagal
tone, as suggested by an assessment of variability in heart rate.
Skeletal muscle dysfunction and wasting may also respond to ex-
ercise training (ExTraMatch 2004).
Although we believe this is the most comprehensive systematic
review to date of RCT based evidence for the impact of exercise
training programmes on patients with heart failure, our review has
a number of limitations. Funnel plot asymmetry for HRQoL is in-
dicative of small study bias and possible publication bias.However,
when regression based adjustment was applied, it was found that
improvement in HRQoL with exercise training remained (SMD
-0.16, 95% CI -0.02 to -0.29) (Moreno 2009). The general lack
of reporting of methods in the included RCT reports made it
difficult to assess their methodological quality and thereby judge
their risk of bias and potential to overestimate the effect of exercise
training programmes. However, they do not appear to be sensi-
tive to risk of bias criteria such as intention-to-treat analysis and
outcome bias. Although a specific goal of this updated review was
to clarify the impact of exercise training programmes on clinical
events, many included trials were relatively small and of short-
term follow up so that the number of deaths and hospitalisations
reported by the majority of trials was small. Indeed, in many stud-
ies we located event data in the trial descriptions of losses to follow
up and exclusions rather that as reported outcomes per se. The
majority of studies were in low to moderate risk males, included
predominantly patients (43% to 100%) with NYHA class II to III
and LVEF < 40%, with a mean age of participants across studies
ranging from 43 to 72 years. The generalisability of our findings
may, therefore, be limited. Although the majority of evidence in
this review comes from the recently reported HF-ACTION study,
the findings of previous trials appear consistent with this impor-
tant trial. Given the time limits for this update, we did not contact
authors for further details.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review shows that exercise training programmes may pro-
vide some important improvements in HRQoL in patients with
NYHA class II or III systolic heart failure and LVEF < 40%, and
may also reduce heart failure-related hospitalisations. There is no
evidence to support that exercise training programmes increase
the risk of death. The effect of exercise training programmes on
total mortality and HRQoL were independent of the degree of
left ventricular dysfunction, type of cardiac rehabilitation, dose of
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exercise intervention, length of follow up, trial quality, and trial
publication date. Aerobic exercise training with or without a resis-
tance exercise element is recommended in a supervised hospital or
home based setting. Given the variation in exercise training pro-
grammes across studies, it was not possibe to provide a definitive
recommendation on the minimum dose of exercise.
Implications for research
To improve generalisability, future trials should include patients
with more severe heart failure, the elderly, people from differ-
ent ethic backgrounds, and women; and report the outcomes by
key patient subgroups (for example with atrial fibrillation or di-
abetes mellitus). Furthermore, there is a need to examine more
home based exercise rehabilitation programmes and how such pro-
grammes canbemost effectively integrated alongside currentmod-
els of service delivery in terms of clinical effectiveness and cost,
such as utilising specialist heart failure nurses. Few of the included
studies reported the actual level of exercise training undertaken by
the participants. Notably, in the HF-ACTION study only 30% of
patients randomised to exercise training exercised at or above their
prescribed level. Future studies need to consider interventions to
enhance the long-term maintenance of exercise training.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Austin 2005
Methods Parallel group RCT
Participants N Randomised: 200 (Exercise 100, Control 100)
Diagnosis (% of pts):
aetiology: ischaemic 77%, hypertension 15.5%, DCM 5.5%, other 2%
NYHA: II: 51.5% ; III: 48.5%
LVEF: 40-35% : 16.5%
<35-30%: 45%
<30%: 38.5%
Case mix: 100% as above
Age: 71.8 (SD 6.8) Control, 71.9 (SD 6.3) Exercise
Percentage male: 43%
Percentage white: Unclear
Inclusion/exclusion criteria:
Inclusion: >60 years, NYHA II or III, & LVSD <40%, confirmed by echocardiography
Exclusion:Diastolic dysfunction, significant co-morbidity preventing entry into study because
of terminal disease or an inability to exercise (e.g. severe musculo-skeletal disorder, unstable
IHD, advanced valvular disease), resident outside the catchment area or in a long-term care
establishment
Interventions Exercise: Total duration: 24 weeks
aerobic/resistance/mix: aerobic endurance training and low resistance training/high repetitive
muscular strength work
frequency: two sessions/week (for 8 weeks) one session/week (16 weeks) plus 3 sessions/week
at home
duration: 2.5 hr class (8 weeks) & 1 hour class (next 16 weeks)
intensity: Not reported
modality: Not reported
Exercise component was based on Eur Cardiac Society & Chartered Society of Physiotherapy
Outcomes Health-related quality of life (Minnesota Living with Heart Failure questionnaire & EuroQol/
EQ-5D); health care utilisation (length of stay of hospital admissions arising from heart disease,
prescribed heart failure medication); mortality
Comparison Standard care group (including monitoring of clinical status, explanation of heart failure & its
treatment self monitoring; dietary advice & contact details of clinical nurse specialist)
Country and Setting UK
Single centre
Follow Up 6 months and 5 years (after randomisation).
Notes
Risk of bias
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Austin 2005 (Continued)
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk ”A computer was used to generate a list of random numbers”
Allocation concealment? Low risk “The numbers, placed in plain sealed envelopes by a university colleague
prior to patient recruitment, were allocated to the participants by a hospital
colleague unconnected with the study. The allocation schedule was not
broken until the trial was completed.”
Blinding?
All outcomes
High risk No, forHRQoL. Data on deaths, admissions from the hospital records
department
Free of selective reporting? Low risk All outcomes described in methods are reported.
Intention to treat analysis? Low risk Although term ITT not stated it appears from CONSORT diagram
that ITT analysis undertaken
Incomplete outcome data? Low risk CONSORT diagram presented showing patient flow. No imputation
or sensitivity analysis to assess impact of loss or follow up
Groups balanced at baseline? Low risk ”There are no significant differences in the baseline parameters of the
standard care and experimental groups.”
Groups received same intervention? Unclear risk Not reported
Belardinelli 1999
Methods Parallel group RCT
Participants N Randomised: 99 (50 exercise; 49 control)
Diagnosis (% of pts):
Aetiology: ischaemic cardiomyopathy (85%) or idiopathic dilated cardiomyopathy (15%)
NYHA: Class II 49%
Class III 34%
Class IV 17%
LVEF: Exercise 28.4 (SD 6) Control 27.9 (SD 5)
Case mix: See above
Age: Exercise 56 (SD 7) Control 53 (SD 9)
Percentage male: 89%
Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: heart failure, LVEF <40%, and sinus rhythm, diagnosis of chronic heart failure based
on clinical symptoms & signs and/or radiological evidence of pulmonary congestion
Exclusion: unstable angina, recent acute myocardial infarction, decompensated congestive heart
failure, hemodynamically significant valvular heart disease, significant chronic pulmonary ill-
ness, uncontrolled hypertension, renal insufficiency (serum creatinine >2.5 mg/dl), and ortho-
pedic or neurological limitations)
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Belardinelli 1999 (Continued)
Interventions Exercise: Total duration: 14 month; eight weeks supervised then 12 months maintenance
aerobic/resistance/mix: aerobic
frequency: 2-3 sessions/wk; duration: 40mins/session; 60% max VO2
modality: cycling
Other: All sessions were held at the hospital gymnasium under the supervision of a cardiologist
Outcomes Health-related quality of life (Minnesota Living With Heart Failure questionnaire); mortality;
morbidity; cost effectiveness
Comparison Standard medical care.
Country and Setting Italy
Single centre
Follow Up 14 and 26 months (after randomisation).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes described in methods, reported in results.
Intention to treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Losses to follow up reported.
Groups balanced at baseline? Low risk “The baseline characteristics of the study population are shown in Table
1. The 2 groups were well balanced with respect to most characteristics,
including peak VO2, New York Heart Association functional class, and
left ventricular ejection fraction. There were no differences in type and
doses of medications, blood chemistry, and previous cardiac events.”
Groups received same intervention? Unclear risk Not reported
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Dracup 2007
Methods Parallel group RCT
Participants N Randomised: 173 (Exercise 86, Control 87)
Diagnosis (% of pts):
aetiology: ischaemic, idiopathic, valvular, DCM, other
NYHA: 2-4
LVEF: 26.4 (SD6.8)
Case mix: 100% as above
Age: 54 (SD12.5)
Percentage male: 71.7
Percentage white: 60.1
Inclusion/exclusion criteria:
Inclusion: English-speaking, aged between 18 to 80 years, NYHA II to IV & LVSD with LVEF
<40% as documented by echocardiogram or radionuclide ventriculography within <6 months,
and sinus rhythm
Exclusion: myocardial infarction or recurrent angina within <3 months, orthopedic impedi-
ments to exercise, severe obstructive pulmonary disease with a forced expiratory volume <1 L
in one second as measured by spirometry, stenotic valvular disease as measured by echocardio-
gram, history of uncontrolled ventricular tachyarrhythmias (documented by electrophysiology
study or 24-hour Holter monitor), or absence of an implantable cardioverter-defibrillator de-
spite a history of sudden cardiac death
Interventions Exercise: Total duration: one year
aerobic/resistance/mix: Mix
frequency: four sessions/week
duration: 10 to 45 mins
intensity: 40 to 60% max HR
modality: walking
Other: ”After six weeks resistive training component involved both upper and lower extremity
strengthening. Resistance training was prescribed at 80% of one repetition maximum, which is the
maximal weight lifted one time, for 2 sets of 10 repetitions using seated biceps curls to strengthen
the arms & seated lateral raises to strengthen shoulders.“
Outcomes Health-related quality of life (Minnesota Living with Heart Failure questionnaire), mortality,
morbidity
Comparison Maintained usual level of daily activities. No exercise component
Country and Setting USA. Single centre.
Home based exercise program.
Follow Up Six and 12 months (after randomisation).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Dracup 2007 (Continued)
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Blinding reported for physical activity (accelerometer) outcopme but
not reported for other outcomes
Free of selective reporting? Low risk All outcomes described in methods reported.
Intention to treat analysis? Unclear risk Although not reported as ITT analysis, groups did appear to be anal-
ysed according to original randomised allocation
Incomplete outcome data? Low risk ”Two patients (one from the experimental and one from the control group)
were lost to follow-up within the first three months of enrollment. One was
incarcerated and the second left the geographic area with no forwarding
information. The remaining 173 patients compose the final study.”
Groups balanced at baseline? Low risk “There were no differences between the control and exercise groups at base-
line with respect to sociodemographic variables (Table I) and most clinical
characteristics. However, patients in the exercise group had a significantly
higher likelihood of having a history of coronary heart disease and taking
antiplatelet medication than in the control group.”
Groups received same intervention? Low risk ”Research nurses made home visits weekly for the first two weeks and then
monthly to assess protocol adherence, correct use of the pedometer, and
tolerance to the exercise program. The home visits also served as a form of
attention control in the care- as-usual group. All clinical questions were
referred to the patient’s cardiologist.”
Giannuzzi 2003
Methods Parallel group RCT
Participants N Randomised: 90, 45 each group
Diagnosis (% of pts):
Aetiology: heart failure secondary to idiopathic dilated cardiomyopathy, ischemic heart disease,
or valvular disease
NYHA: 2-3
LVEF: <35%
Case mix: 100%
Age: Exercise 60 (SD 7), Control 61 (SD 7)
Percentage male: Not stated
Percentage white: Not stated
Inclusion/exclusion criteria:
Inclusion: (1) heart failure secondary to idiopathic dilated cardiomyopathy, ischemic heart
disease, or valvular disease; (2) echocardiographic ejection fraction <35%; (3) clinical stability
for at least 3 months under optimized therapy; (4) New YorkHeart Association functional class
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Giannuzzi 2003 (Continued)
II to III; (5) peak oxygen uptake (VO2) < 20 ml/kg/min; and (6) echocardiographic images of
adequate quality for quantitative analysis
Exclusion: any systemic disease limiting exercise, hypertrophic cardiomyopathy, valvular dis-
ease requiring surgery, angina pectoris, sustained ventricular arrhythmias, severe hypertension,
excess variability (>10%) at baseline cardiopulmonary exercise test, and inability to participate
in a prospective study for any logistic reason.
Interventions Exercise:
Total duration: six months
frequency: three-five sessions/week
duration: 30mins
intensity: 60% peak VO2
modality: Exercise cycle, daily brisk walk, callisthenic. Also, requested to take brisk daily walk
of >30mins
Other: not stated
Outcomes Mortality and morbidity.
Comparison Educational support but no formal exercise protocol.
Country and Setting Italy
Multicentre (15 Cardiac rehabilitation units)
Follow Up six months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes reported in methods are reported.
Intention to treat analysis? Low risk Although not stated, it is clear from CONSORT diagram that two
groups were analysed according to ITT
Incomplete outcome data? Low risk 45/45 (100%) exercise training group and 44/45 (98%) available at
6-months follow up
Groups balanced at baseline? Low risk ”No significant differences were observed between the 2 groups with respect
to demographic and clinical data, including age, weight, cause of heart
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Giannuzzi 2003 (Continued)
failure, or NewYorkHeart Association functional class. Furthermore, there
was no difference between the 2 groups in the medications received during
the 6-month period of the study.”
Groups received same intervention? Unclear risk Not clearly stated if co-treatments (i.e. cardiovascular medication) in
two groups were the same
Gielen 2003
Methods Parallel group RCT
Participants N Randomised: 20 (Exercise 10, Control 10)
Diagnosis (% of pts):
aetiology: IHD, DCM
NYHA: Class II: 90%
Class III 10%
LVEF: Exercise mean 26.1% (SD 6), Control mean 24.7% (SD 8)
Case mix: 100% as above
Age: Exercise: 55 (SD 6) Control 53 (SD 9),
Percentage male: 100%
Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: <70 years with CHF (NYHA II to III) as result of dilated cardiomyopathy or IHD
as assessed by cardiac catheterization. All had clinical, radiologic, and echocardiographic signs
of CHF and a LVEF 40% as assessed by ventriculography and clinically stable condition for
>3 months before enrolment
Exclusion: significant valvular heart disease, uncontrolled hypertension, peripheral vascular
disease, pulmonary disease, or musculoskeletal abnormalities precluding exercise training
Interventions Exercise: Total duration: two weeks inpatient followed by six months outpatient.
aerobic/resistance/mix: aerobic
frequency: seven sessions/wk
duration: 20 mins/session
intensity: 70% symptom limited VO2 max
modality: cycle ergometers.
Other: Expected to participate in one group training session (walking, callisthenics, and non-
competitive ball games) of 60 min each week
Outcomes Mortality
Comparison Continued their sedentary lifestyle and remained on their individually tailored cardiac medi-
cation supervised by their private physicians
Country and Setting Switzerland
Single centre
Follow Up 26 weeks (after randomisation)
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Gielen 2003 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes described in methods are reported in results.
Intention to treat analysis? Unclear risk Although ITT analysis not reported, groups do appear to analysed
according to original randomised allocation
Incomplete outcome data? Low risk No loss to follow up.
Groups balanced at baseline? Low risk “Patients in the training group and in the control group showed a signifi-
cantly reduced left ventricular ejection fraction (training group: 26.1 ±3.
1%, control group: 24.7± 2.4%; NS) and exercise capacity as determined
by peak oxygen uptake (training group: 20.3 ±1.0 ml/kg min, control
group: 17.9 ±1.6 ml/kg min; P NS).”
Groups received same intervention? Unclear risk Details of co-interventions not reported.
Gottlieb 1999
Methods Parallel group RCT
Participants N Randomised: 33
Diagnosis (% of pts):
aetiology: ischaemic or primary
NYHA: 2-3
LVEF: <40%
Case mix: 100% as above
Age: Control 64 (SD 10), Exercise 67 (SD 7)
Percentage male: Control 11/14 (79%), Exercise 15/16 (94%)
Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: NYHA 2-3 for at least three months and were on stable meds for the past one
month. All patients were on maximal medical therapy with ACEi, diuretic and digoxin. All
patients had EF<40% by nuclear ventriculography. No patient had obstructive valvular disease,
myocardial infarction within three months, or limitation of exercise secondary to angina or
new arrhythmias
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Gottlieb 1999 (Continued)
Exclusion: Not reported.
Interventions Exercise: Total duration: three months
aerobic/resistance/mix: aerobic
frequency: three session/week;
duration: not reported
intensity: Borg 12-13
modality: bike and treadmill
Other: Care provided by specialist heart failure physician.
Outcomes Health-related quality of life (Minnesota Living with Heart Failure & MOS Short-Form 36
questionnaires), mortality, morbidity
Comparison Usual medical care
Other: Care provided by specialist heart failure physician
Country and Setting USA
Single centre
Follow Up six months (after randomisation)
Notes MLWHF, MOS SF-36 results not reported for the control group.
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes described in methods are reported.
Intention to treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Yes, QUORUM flow diagram reported.
Unclear how loss to follow up, drop-out and cross-over dealt with
Groups balanced at baseline? Low risk There were no differences at baseline between patients randomised to the
control group and those randomised to the exercise program.
Groups received same intervention? Low risk Medical follow-up of both the control and intervention patients groups
was provided by specialized heart failure physicians.
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Methods Parallel group RCT
Participants N Randomised: 22 (12 exercise & 10 control)
Diagnosis (% of pts):
aetiology: DCM (86%) or ischaemic heart disease (14%)
NYHA: Class II (55%)
Class III (45%)
LVEF: Exercise 26% (SD 9); Control 27% (SD 10)
Case mix: 100% as above
Age: Exercise 50 (SD 12); Control 52 (SD 8)
Percentage male: 100%
Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: EF<40% as assessed by radionucleotide scintigraphy, and a reduced fractional short-
ening <30% assessed by echocardiography; willingness to participate in the study for the next
6 months; and a permanent residence within 25km of the training facility. Physical work ca-
pacity at baseline >25Watts without signs of myocardial ischaemia (i.e. angina or ST segment
depression). Clinically stable >3 months.
Exclusion: Exercise induced myocardial ischaemia or ventricular tachyarrhythmias (higher then
Lown class IVa), valvular heart disease, uncontrolled hypertension, peripheral vascular disease,
COPDandorthopaedic or other conditions precluding regular participation in exercise sessions
Interventions Exercise: Total duration: six months
aerobic/resistance/mix: aerobic
frequency: four-six sessions/wk
duration: 10-60 mins/session, one hour at home
intensity: 70% VO2max
modality: cycling, walking, ball games and callisthenics
Other: First three weeks supervised hospital based training; thereafter home-based.
Outcomes Morbidity and mortality.
Comparison After discharge medical therapy continued and patients supervised by private physician
Country and Setting Germany
Single centre
Follow Up Six months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
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Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes described in methods, reported in results.
Intention to treat analysis? Unclear risk Not reported
Incomplete outcome data? Low risk Drop-outs and clinical events are fully reported for both groups. No
imputation undertaken
Groups balanced at baseline? Low risk “There were no significant differences in baseline variables between the
training and control groups.”
Groups received same intervention? Unclear risk The exercise group had three weeks of hospital stay, the control only
three. The control group follow up with private physician. No com-
ment on follow up of intervention group
Hambrecht 1998
Methods Parallel group RCT
Participants N Randomised: 20 (10 exercise, 10 control)
Diagnosis (% of pts):
aetiology: IHD 35%, DCM 65%
NYHA: class II - 65% & class III: 35%
LVEF: <40%; Exercise; mean 24% (SD 13), Control 23% (SD 10%)
Case mix: as above
Age: Exercise 54 (SD 9), Control 56 (8)
Percentage male: 100%
Percentage white: not reported
Inclusion/exclusion criteria:
Inclusion: <70 years old, with CHF as a result of DCM or IHD.
Exclusion: DM, hypertension, overt atherosclerotic peripheral vascular disease, hypercholes-
terolaemia, ventricular tachycardia, COPD and primary valvular disease
Interventions Exercise: Total duration: six months
aerobic/resistance/mix: Aerobic
frequency: two-six sessions/day
duration: 10-20 mins/session
intensity: 70% VO2 max
modality: Bike ergogometer.
Other: plus one group session/week.
Outcomes Mortality
Comparison Description: Stayed on previous medication, continued sedentary lifestyle, and supervised by
their private physicians
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Country and Setting Germany
Single centre
Follow Up Six months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes described in methods reported in results.
Intention to treat analysis? Unclear risk It appears that groups are analysed according to original randomised
allocation
Incomplete outcome data? Low risk Detailed description of losses to follow and drop-outs reported
Groups balanced at baseline? Low risk ”At baseline, patients in the control group did not differ significantly from
those in the training group with respect to age, aetiology of heart failure,
NYHA functional class, duration of heart failure, LVEFEF or LVEDD.”
Groups received same intervention? Low risk ”Patients were on angiotensin-converting enzyme inhibitors (100% in
both groups), diuretics (training group 82%, control 70%), and digoxin
(training 73%, control 70%, P5NS). Drug treatment did not change
between 4 weeks before enrolment and study termination.”
Hambrecht 2000
Methods Parallel group RCT
Participants N Randomised: 73 (exercise 36; control 37)
Diagnosis (% of pts):
Aetiology: IHD 16%; DCM 84%
NYHA: Class I & II: 74%
Class III: 26%
LVEF: 29% (SD 9)
Case mix: 100% as above.
Age: Exercise 54 (SD 9), Control 54 (SD 8)
Percentage male: 100
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Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: documented heart failure by signs, symptoms and angiographic evidence of reduced
LV function (LVEF<40%) as a result of DCM or IHD; physical work capacity at baseline
>25W, clinical stability ?3 months before study start
Exclusion: significant valvular heart disease, uncontrolled hypertension, DM, hypercholestero-
laemia, PVD, pulmonary disease, musculoskeletal abnormalities precluding exercise training
Interventions Exercise: Total duration: Six-months
aerobic/resistance/mix: Aerobic
frequency: six-seven sessions/wk
duration: 10-20/session
intensity: 70% of peak VO2
modality: Cycle ergometer
Other: Plus group sessions one hour twice weekly, walking, ball games and callisthenics. First
two weeks in hospital, remainder home based
Outcomes Mortality
Comparison Continued individually tailored cardiac medications, supervised by their physicians
Country and Setting Germany
Single centre
Follow Up Six months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk “Patients were randomly assigned to either a training group or an inactive
group sing a list of random numbers.”
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes described in methods reported in results.
Intention to treat analysis? Low risk Not reported
Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow up reported.
Groups balanced at baseline? Low risk ”No significant differences were observed between the two groups with
regard to demographic or clinical data, including age, weight, LVEF,
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LVEDD, NYHA or maximum oxygen uptake.”
Groups received same intervention? Unclear risk The co-interventions in the control group not reported.
HF ACTION 2009
Methods Parallel RCT
Participants N Randomised: 2331 (exercise 1159; control 1172)
Diagnosis (% of pts):
Aetiology: IHD 51%
NYHA: Class II: 63%
Class III: 35%
Class IV: 1%
LVEF: 25% (SD not reported)
Case mix: 100% as above.
Age: Exercise 59 (SD not reported), Control 59 (SD not reported)
Percentage male: 72%
Percentage white: 62%
Inclusion/exclusion criteria:
Inclusion: LVEF <35%, NYHA class II-IV heart failure for the previous three months despite
a six week period of treatment, optimal heart failure therapy at stable doses for six weeks be-
fore, enrollment or documented rationale for variation, including intolerance, contraindica-
tion, patient preference, and personal physicians judgment, sufficient stability, by investigator
judgment, to begin an exercise program
Exclusion: (selected) Age <18 yr, comorbid disease or behavioral or other limitations that inter-
fere with performing exercise training or prevent the completion of one yr of exercise training,
major cardiovascular event or cardiovascular procedure, including implantable cardioverter
defibrillator (ICD) use and cardiac resynchronization, within the previous six wks
Interventions Exercise: Total duration: period of study (three months supervised, remainder home based)
aerobic/resistance/mix: Aerobic
frequency: three-five sessions/wk
duration: 15-35 mins/session
intensity: 60-70% of heart rate reserve
modality: Cycling or walking
Other: First 36 sessionswere supervised then advised to followhomebased exercise programme
Outcomes Mortality, hospitalisation, and health-related quality of life (Kansas City Cardiomyopathy
Questionnaire - KCCQ)
Comparison Usual care: all patients, regardless of group allocation, received self-mamagement educational
materials consistent with guidelines of American College of Cardiology and American Heart
Association
Country and Setting USA
Multicentre
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Follow Up Median 30.1 months (after randomisation).
Notes Authors contacted for further details of outcome findings but no information provided
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk “The trial uses a permuted block randomization scheme stratified by
center and by the etiology of the patient’s heart failure (ischemic vs
nonischemic)”
Allocation concealment? Low risk “patients are randomized at the enrolling centers using an interactive
voice response”
Blinding?
All outcomes
Low risk Event outcomes were blinded.
Free of selective reporting? Low risk All outcomes described in methods reported in results.
Intention to treat analysis? Low risk
Incomplete outcome data? Low risk QUORUM diagram and details of losses to follow up reported.
Groups balanced at baseline? Low risk Table 1 shows two groups are well balanced.
Groups received same intervention? Low risk “All patients, regardless of group allocation, received self-mamagement
educational materials...consistent with guidelines of American College
of Cardiology and American Heart Association”
Keteyian 1996
Methods Parallel group RCT
Participants N Randomised: 40 (exercise 21; control 19)
Diagnosis (% of pts):
aetiology: DCM 40% , IHD 60%
NYHA: Class II 67.5%
Class III 32.5%
LVEF: 21% (SD 7)
Case mix: 100% as above
Age: 56 (SD 11)
Percentage male: 100%
Percentage white: 62.5% (remainder black)
Inclusion/exclusion criteria:
Inclusion: NYHA class II or III, a resting EF ?35% measured by echocardiography or gated
equilibrium radionuclide angiography, and no change in medical therapy ?30 days before
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randomisation
Exclusion: atrial fibrillation, acute myocardial infarction ?3 months, angina pectoris at rest or
induced by exercise, current enrolment in another clinical trial, and current participation in a
regular exercise program (at least twice weekly).’
Interventions Exercise: Total duration: 24 weeks
aerobic/resistance/mix: aerobic
frequency: three sessions/wk (RPE 12-14)
duration: 33mins; intensity: 60-80% peak HR
modality: treadmills, stationary cycles, rowing machines, and arm ergometers.
Outcomes Morality and hospital admissions
Comparison Not reported
Country and Setting North America
Single centre
Follow Up Six months (after randomisation)
Notes Authors contacted for further details of outcome findings but no information provided
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk “patients were randomly assigned to the exercise group or the control group.
”
Allocation concealment? Unclear risk “Each patient’s assignment was sealed in an envelope until completion of
the second exercise test.”
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes described in methods reported in results.
Intention to treat analysis? Low risk “Of the 40 patients entered into the study, only those who also completed
the exercise tests at weeks 12 and 24 were considered in the data analysis.”
Incomplete outcome data? Low risk “Fifteen patients in the exercise group completed the study. Two patients
dropped out because of noncardiac medical conditions (progressive, lim-
iting arthritis in one patient and newly diagnosed cancer in the other)
that developed within 1 month of the start of the exercise program. One
patient developed atrial fibrillation between week 12 andweek 24; 3 other
patients stopped exercising for personal reasons before week 12 and refused
follow-up testing. Fourteen of the 19 patients in the control group com-
pleted the study. Two dropped out for personal reasons and refused follow-
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up testing, one developed atrial fibrillation between week 12 and week
24, one was hospitalized at week 22 for an acute myocardial infarction,
and one died suddenly.”
Groups balanced at baseline? Low risk “Among patients who completed the study, no differences in demographic
characteristics were seen between the two study groups after randomization.
”
Groups received same intervention? Unclear risk The co-interventions in the control group not reported.
Klecha 2007
Methods Parallel group RCT
Participants N Randomised: 50 (Exercise 25, Control 25)
Diagnosis (% of pts):
aetiology: IHD 100%
NYHA: class II Exercise 56%, Control 60%
Class III: Exercise 44% Control 40%)
LVEF: Exercise mean 27.4% (SD 5.7); Control: 28.5% (SD 5.2)
Case mix: 100% as above
Age: Exercise 59.6 (SD 10.2), Control 61.2 (SD 9.5)
Percentage male: exercise 80%, Control 72%
Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: Ischaemic heart failure in NYHA groups II-III of > six months, clinically stable > six
weeks & LVEF <35%
Exclusion: Uncontrolled arterial hypertension, history of major ventricular arrhythmias, ACS,
PCI or brain event 3 months prior to the study, AF or other arrhythmia making it impossible
to perform MRI, previous coronary artery bypass grafting, implantable cardiodefibrillator
, permanent pacemaker, or the presence of metal parts in the body, signs of osteoarticular
dysfunction excluding participation in physical training, diabetesmellitus, COPDand anaemia
Interventions Exercise: Total duration : six months
aerobic/resistance/mix: aerobic
frequency: three sessions/week
duration: 25 mins/session
intensity: 80% predicted HR at VO2 max
modality: Cycling.
Outcomes Mortality
Comparison Standard medical care only.
Country and Setting Poland
Single centre
Follow Up 26 weeks (after randomisation).
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk All outcomes described in methods reported in results.
Intention to treat analysis? Unclear risk Not implicit but numbers used suggest that groups analysed according
to randomised allocation
Incomplete outcome data? Low risk No patients lost to follow up.
Groups balanced at baseline? Low risk ”At baseline the groups did not differ significantly in clinical characteris-
tics. The only exception was smoking, the training group consisted of sig-
nificantly more ex-smokers.”
Groups received same intervention? Unclear risk Not reported
Klocek 2005 (High)
Methods Parallel randomised controlled trial
Participants N Randomised: 42 (14 Exercise group B, 14 control)
Diagnosis (% of pts):
aetiology: Ischaemic 100%
NYHA: Class II/III Exercise group B: 75%; Control; 100%
LVEF: Exercise group B: ,mean 34.2% (SD 4.2); Control 33.2% (SD 3.8)
Case mix: 100% as above
Age: Exercise group B: 57 (SD 8), Control 55 (SD 9)
Percentage male: 100%
Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: Stable chromic heart failure, LVEF < 40% on echocardiography ? one month before
inclusion, age <65 years.”
Exclusion: Moderate or severe pulmonary disease, orthostatic blood pressure fall (>20mmHg), or
with myocardial infarction, unstable angina, heart surgery or coronary angioplasty within 3 months
prior to inclusion as well as inability to perform bicycle training.
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Interventions Exercise: Total duration: six months
aerobic/resistance/mix: aerobic
frequency: three sessions/week
duration: Group B - 25 mins/session (exercise workload gradually increased after each five
minute training period to a total of 25 minutes); intensity: Group B: up to 75% max HR;
modality: Cycle ergometer.
Outcomes HRQoL (Psychological general Wellbeing index, PGWB).
Comparison Controls were asked not to change their degree of physical activity during the study
Country and Setting Poland
Single centre
Follow Up 26 weeks (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk ”Results of baseline QoL examinations were not known to
the patients and their physicians or to the persons perform-
ing the randomisation”.
Free of selective reporting? Low risk All outcomes described in methods are reported in re-
sults.
Intention to treat analysis? Unclear risk It appears that groups were analysed according to initial
random allocation
Incomplete outcome data? Unclear risk No information presented on loss on loss to follow up
or drop-outs
Groups balanced at baseline? Low risk “At baseline there were no significant differences in between
groups in left ventricular ejection fraction and other basic
parameters of left ventricular function.” ”At the start of
the study, mean PGWB total index was similar in groups
A and B. Controls had lower total index than patients in
group B”.
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Groups received same intervention? Unclear risk Details of co-interventions not reported although degree
of follow up was stated to equivalent
Klocek 2005 (Low)
Methods Parallel group RCT
Participants N Randomised: 42 (14 Exercise group A 14 control)
Diagnosis (% of pts):
aetiology: Ischaemic 100%
NYHA: Class II/III Exercise group A 55%; Control 100%
LVEF: Exercise Group A: mean 33.6% (SD 3.6); Control 33.2% (SD 3.8)
Case mix: 100% as above
Age: Exercise group A 54 (SD 7), Control 55 (SD 9)
Percentage male: 100%
Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: Stable chromic heart failure, LVEF < 40% on echocardiography ? one month before
inclusion, age <65 years.”
Exclusion: Moderate or severe pulmonary disease, orthostatic blood pressure fall (>20mmHg), or
with myocardial infarction, unstable angina, heart surgery or coronary angioplasty within 3 months
prior to inclusion as well as inability to perform bicycle training.
Interventions Exercise: Total duration: six months
aerobic/resistance/mix: aerobic
frequency: three sessions/week
duration:Group A - 20 minutes/session (four minute constant workload with one minute rest
repeated five times). intensity: Group A - 60% max HR; ; modality: Cycle ergometer.
Outcomes HRQoL (Psychological general Wellbeing index PGWB).
Comparison Description: Controls were asked not to change their degree of physical activity during the
study
Country and Setting Poland
Single centre
Follow Up 26 weeks (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
42Exercise based rehabilitation for heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Klocek 2005 (Low) (Continued)
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk ”Results of baseline QoL examinations were not known to the patients and
their physicians or to the persons performing the randomisation”.
Free of selective reporting? Low risk All outcomes described in methods are reported in results.
Intention to treat analysis? Unclear risk It appears that groups were analysed according to initial random allo-
cation
Incomplete outcome data? Unclear risk No information presented on loss on loss to follow up or drop-outs
Groups balanced at baseline? Low risk “At baseline there were no significant differences in between groups in left
ventricular ejection fraction and other basic parameters of left ventricular
function.” ”At the start of the study, mean PGWB total index was similar
in groups A and B. Controls had lower total index than patients in group
B”.
Groups received same intervention? Unclear risk Details of co-interventions not reported although degree of follow up
was stated to be equivalent
Koukouvou 2004
Methods Parallel randomised controlled trial
Participants N Randomised: 26 (16 Exercise group, 10 control)
Diagnosis (% of pts):
aetiology: DCM 7%/Ischaemic 100%
NYHA: Class II: 58%; Class III: 42%
LVEF: < 40%
Case mix: 100% as above
Age: Exercise group: 52 (SD 9), Control 53 (SD 11)
Percentage male: 100%
Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion: Aetiology of CHF was either ischaemic heart disease or dilated cardiomyopathy.
Diagnosis of CHF was mainly based on clinical signs (NYHA II and III), radiological findings,
and echocardiographically determined ejection fraction < 40% and shortening fraction < 30%
Exclusion: recent myocardial infarction or unstable angina, aortic stenosis, diabetes mellitus,
uncontrolled hypertension, musculoskeletal limitations or other contraindications for partici-
pating in an exercise training program, documented exercise-induced severe ischaemia and/or
serious arrhythmias
Interventions Exercise: Total duration: six months
aerobic/resistance/mix: mix
frequency: three-four sessions/week
duration: 60mins/session; intensity: 50-75% peak VO2; modality: Cycle ergometer, walking or
jogging, stair climber and step-aerobics
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Plus “light” resistance exercise (not defined).
Outcomes HRQoL (Minnesota Living with Heart Failure and Spritzer Quality of Life Index)
Comparison No stated
Country and Setting Greece
Single centre
Follow Up Six months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Low risk “The psychological tests were assessed from all patients in
the first week of admission, before randomization to study
groups and the end of the study by the same physician, who
was not familiar with the patients.”
Free of selective reporting? Low risk All outcomes outlined in methods are reported.
Intention to treat analysis? Unclear risk Not stated explictly but appear to analysed according to
initial group allocation
Incomplete outcome data? Unclear risk Losses to follow up, drop-outs not reported.
Groups balanced at baseline? Low risk “The two groups of patients participating in the study were
similar as regards their clinical data”.
Groups received same intervention? Unclear risk Not reported
McKelvie 2002
Methods Parallel grout RCT
Participants N Randomised: 181 (Exercise: 90 & Control: 91)
Diagnosis (% of pts):
aetiology: Ischaemic (76%), hypertensive (7%), valvular (5%), other (12%)
NYHA: one-three
LVEF: <40%
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Case mix: 100% as above
Age: Control: 66.1 (SD 9.4), Exercise: 64.8±1.1 (SD 10.5)
Percentage male: Control 80, Exercise 82
Percentage white: Unclear
Inclusion/exclusion criteria:
Inclusion: documented clinical signs and symptoms of heart failure; left ventricular ejection
fraction <40%; New York Heart Association Functional class I to III; and 6-minute walk test
distance < 500 metres
Exclusion: inability to attend regular exercise training sessions; exercise testing limited by angina
or leg claudication; abnormal blood pressure response to exercise testing (systolic blood pres-
sure during exercise >250 mm Hg or diastolic blood pressure response >15 mm Hg, systolic
blood pressure response decrease of >20 mm Hg after a normal increase or decrease below the
resting level); cerebrovascular or musculoskeletal disease preventing exercise testing or train-
ing; respiratory limitation (forced expired volume in one second and/or vital capacity <60%
of predicted); poorly controlled cardiac arrhythmias; and any noncardiac condition affecting
regular exercise training or decreasing survival
Interventions Exercise: Total duration: nine months (three supervised, six home based)
aerobic/resistance/mix:Mix
frequency: two sessions/week
duration: Aerobic; 30 mins/session
intensity: Aerobic; 60-70% max heart rate. Resistance; 40% of 1-repetition maximum, with 10
repetitions for the arm exercises and 15 repetitions for the leg exercises, with an increase over
five weeks to an intensity of 60% of 1-repetition maximum and a total of three sets of each
exercise per session
modality: Aerobic; cycle, treadmill, and arm ergometry exercise. Resistance; arm curl, knee
extension, and leg press performed individually with each limb
Other: After three months of supervised training, patients in the exercise group were provided
an exercise cycle and set of free weights with instructions to continue training at home three
times per week for the remainder of the study
Outcomes Health-related quality of life (Minnesota Living with Heart Failure Questionnaire), mortality,
Composite of mortality & hospital admission for heart failure
Comparison Usual medical care. Control patients were not provided with a formal exercise prescription but
were encouraged to continue their usual level of physical activity and were not discouraged
from regular physical activity
Country and Setting Canada
Multicentre
Follow Up 12 months (after randomisation).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Adequate sequence generation? Low risk “The predetermined allocation sequence was based on a stream of com-
puter-generated pseudorandomnumbers from auniformdistribution strat-
ified by center and with a blocking factor of 4.”
Allocation concealment? Low risk ”Eligible patients were registered in a log and treatment group determined
by opening the next sequential study allocation envelope.”
Blinding?
All outcomes
Low risk “Outcome measures were performed in a blinded fashion. Individuals re-
sponsible for supervising and recording the results of the outcome measure-
ments were unaware of the patients group assignment.”
Free of selective reporting? Unclear risk All outcomes described in methods are reported in results.
Intention to treat analysis? Unclear risk Although ITT analysis not reported, groups do appear to analysed
according to original randomised allocation
Incomplete outcome data? Low risk ”In the control group, 83 patients completed 3months of follow-up (reasons
for incompletion: death 3; other problems 4; worsening heart failure 1) and
75 patients completed 12months of follow-up (reasons for incompletion:
death 8; withdrawal 2; other problems 3; worsening heart failure 2; refused
testing 1).
For the exercise group, 80 patients completed 3months of follow-up (reasons
for incompletion: death 1; withdrawal 5; other problems 1; worsening
failure 2; refused testing 1) and 64 patients completed 12months of follow-
up (reasons for incompletion: death 9; withdrawal 6; other problems 7;
worsening heart failure 3; refused testing 1).”
No imputation or sensitivity analysis undertaken to assess impact of
loss to follow up
Groups balanced at baseline? Low risk “There were no differences between the control and exercise training groups
with respect to age, resting ejection fraction, New York Heart Association
class, cause of heart failure, or duration of heart failure.”
Groups received same intervention? Unclear risk ”All patients were reviewed monthly throughout the study”.
Mueller 2007
Methods Parallel group RCT
Participants N Randomised: 50 (25 exercise, 25 control)
Diagnosis (% of pts):
aetiology: ischaemic and DCM (%s nor reported)
NYHA: Not reported
LVEF: <40% (%s not reported)
Case mix: 100% as above
Age: 55 (SD 10)
Percentage male: 100%
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Percentage white: Not reported
Inclusion/exclusion criteria:
Inclusion:Chronic heart failure was documented by clinical, angiographic or echocardiographic
criteria, and a resting ejection fraction <40%
Exclusion: Not reported.
Interventions Exercise: Total duration: one month
aerobic/resistance/mix: aerobic
frequency: five sessions/wk; duration: 30min/session cycling, 90minwalking each day; intensity:
Borg 12-14 (60-80% max HR); modality: cycling and walking.
Other: Resided at the rehabilitation centre for one month.
Outcomes Morbidity and mortality
Comparison Usual medical care
Country and Setting Switzerland
Single centre
Follow Up 6.2 years (after randomisation).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk Outcomes described in the methods are reported in the results
Intention to treat analysis? Unclear risk ITT not stated explicitly. However, groups appear to analysed accord-
ing to original allocation
Incomplete outcome data? Low risk ”Data from one patient in the control group was not available at the two-
month evaluation due to refusal to complete testing.”-Among subjects in
the exercise group, 9 died, and one refused repeat testing. Among patients
in the control group, 12 died and two refused repeat testing. Therefore, 14
and 13 patients performed six-year evaluations in the exercise and control
groups, respectively.” QUORUM diagram reported and detailed text.
No imputation undertaken
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Groups balanced at baseline? Low risk “No differences were observed between the exercise and control groups
initially in clinical or demographic data, including age, height, weight,
pulmonary function or medication status.”
Groups received same intervention? Unclear risk ”Patients in the exercise group resided at the rehabilitation centre for one
month. Control subjects received usual clinical care, including verbal en-
couragement to remain physically active.”
Passino 2006
Methods Parallel group RCT
Participants N Randomised: 95 (Training: 47; Control: 48)
Diagnosis (% of pts): *
aetiology: Ischaemic:59%, DCM: 41%
NYHA: Class I: 16%
Class II: 69%
Class III: 34%
LVEF: Training: 35% (SD 9.3), Control 32.3 (SD 14.1)
Case mix: 100% as above
Age: Exercise 60 (SD 13), Control 61 (SD 13)
Percentage male: 87%
Percentage white: not reported
Inclusion/exclusion criteria:
Inclusion: impaired left ventricular systolic function (EF<45%) and exercise capacity (peak
VO2<25 ml/min/kg).
Exclusion NYHA class IV, myocardial infarction or unstable angina <6 months before the
examination, exercise-limiting diseases, and severe pulmonary or renal disease
* baseline data only available in 85 patients.
Interventions Exercise: Total duration: nine months
aerobic/resistance/mix: aerobic; frequency: >3 sessions/week
duration: 30 mins/session
intensity: 65% max VO2
modality: Cycle
Other: Not reported.
Outcomes Health-related quality of life (Minnesota Living with Heart Failure Questionnaire)
Morbidity
Comparison Not reported
Country and Setting Italy
Multicentre
Follow Up Nine months (after randomisation).
Notes
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Passino 2006 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Exercise test assessor blinded.
Free of selective reporting? Unclear risk Not reported
Intention to treat analysis? Unclear risk Although ITT not stated, groups appeared to be analysed according
to original randomisation
Incomplete outcome data? Low risk Outcomes described in methods reported in results.
Groups balanced at baseline? Low risk ”The two groups did not differ as to age, gender, NYHA functional class,
EF, pharmacologic treatment, or HF etiology (Table 1).”
Groups received same intervention? Low risk “Patients in [control] group underwent follow-up visits at the third and
ninthmonth to exclude changes in their usual lifestyle and physical activity.
”
Pozehl 2008
Methods Parallel group RCT
Participants N Randomised: 21 (exercise 15, control six)
Diagnosis (% of pts):
aetiology: Ischaemic: 71% & non-ischaemic: 29%
NYHA: Class II: 39%
Class III: 52%
Class IV: 9%
LVEF: Exercise 27.9% (SD 7.0), Control 29.7% (SD 8.7)
Case mix: 100% as above
Age: Exercise 66.3 (SD 9.6), Control 66 (SD 12.6)
Percentage male: 90%
Percentage white: 100%
Inclusion/exclusion criteria:
Inclusion: able to speak and read English; stable NYHA class II-IV no change in medical
therapy ?30 days; resting LVEF <40% measured by echocardiography or gated equilibrium
radionuclide angiography; medical diagnosis of heart failure either ischemic or non-ischaemic;
and standard pharmacologic therapy for heart failure (diuretics, ACE inhibitors, and beta-
blockers)
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Pozehl 2008 (Continued)
Exclusion: participation in a formal exercise program <30 days prior to this study; clinical
evidence decompensated heart failure; and any of the following medical conditions: atrial
fibrillation, acute myocardial infarction <3 months, unstable angina pectoris, end-stage renal
disease, or orthopedic impediments to exercise
Interventions Exercise: Total duration : 24 weeks
aerobic/resistance/mix:mix
frequency: three sessions/week; duration: 30 mins aerobic, 20 mins resistance; intensity: 60-85%
max VO2, 12-14 Borg scale
modality: Aerobic: treadmill, stationary bike, rower, arm ergometer; Resistance: light upper-
body exercises (military press, biceps curl, and lateral deltoid raises) and lower-body exercises
(knee extension, side hip raise, and hip extension) with 1?10 lb hand and ankle weights. Wall
push-ups, abdominal curl-ups, and/or pelvic tilts
Other: Strategies from social learning theory (goal-setting, feedback and problem-solving guid-
ance) utilised to facilitate, improve adherence to the training program
Outcomes Mortality
Comparison Usual medical care
Country and Setting USA
Single centre
Follow Up Six months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Unclear risk Not reported
Free of selective reporting? Low risk Outcomes described in methods are reported in results.
Intention to treat analysis? Unclear risk Although not stated, groups appear to analysed according to initial
randomised allocation
Incomplete outcome data? Low risk “one subject in the control group died of myocardial infarction and one
subject in the exercise training groupwas diagnosedwith cancer and unable
to continue the exercise training.” No imputation undertaken.
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Pozehl 2008 (Continued)
Groups balanced at baseline? Low risk ”Subjects did not differ in fatigue or dyspnea by type of HF (ischemic vs.
nonischemic) or years since diagnosis of HF (length of time since diagnosis)
.”
Groups received same intervention? Unclear risk Not reported
Willenheimer 2000
Methods Parallel group RCT
Participants N Randomised: 54, (27 exercise & 27 control)
Diagnosis (% of pts):*
aetiology: 75% ischaemic, 25% non-ischaemic
NYHA: 2.2 (SD 0.7) & 2.5 (0.7)
LVEF: 55% (SD 11) & 36% (SD 11)
Case mix: 100% as above
Age: 64 (SD 5) Training and 64 (SD 9) Control
Percentage male: 73% Training and 70% Control
Percentage white: Unknown
Inclusion/exclusion criteria:
Inclusion: 1) Eight points on Boston heart failure criteria; 2) left ventricular ejection fraction
0.45 at the most recent radionuclide or echocardiographic examination (not older than one
year at inclusion); and 3) 75 years of age
Exclusion: 1) change of clinical status and / or medication within four weeks prior to inclusion;
2) myocardial infarction, heart surgery, or coronary angioplasty within three months prior
to inclusion; 3) inability to perform a bicycle test; 4) exercise-terminating angina pectoris,
ST-depressions ( >2 mm in >1 lead), blood pressure fall (>.10 mm Hg), or arrhythmia (e.
g. ventricular tachycardia /fibrillation, ventricular extrasystoles, supraventricular tachycardia
>170 beats / min) at the most recent maximal exercise test ( including the baseline test ); 5)
pulmonary disease judged to be the main exercise-limiting factor and/or peak expiratory flow
rate <50% of the age- and sex-adjusted reference value; 6) New York Heart Association class
IV; and 7) clinically significant aortic stenosis.
Interventions Exercise: Total duration: four months
aerobic/resistance/mix: aerobic/interval
frequency: two-three sessions per week
duration: 15 mins/session increasing to 45 mins/session
intensity: 80% peak VO2, or 15 on Borg score
modality: cycle ergometry.
Outcomes HRQoL (Patient’s Global Assessment of Quality of Life, PGACQoL), mortality
Comparison Control patients were asked not to change their degree of physical activity during the active
study period. Neither training patients nor controls were instructed regarding physical activity
during the six-month extended follow up
Country and Setting Sweden
Single centre
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Willenheimer 2000 (Continued)
Follow Up 10 months (after randomisation)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported
Allocation concealment? Unclear risk Not reported
Blinding?
All outcomes
Low risk Outcome assessors blinded. Patients, clinical care-givers not blinded
Free of selective reporting? Low risk All outcomes described in methods reported in results.
Intention to treat analysis? Unclear risk Although ITT not implicit, it appears that groups are analysed accord-
ing to original randomised allocation
Incomplete outcome data? High risk Outcome available in only 43/54 (80%) patients randomised at 10-
months follow up. No imputation or sensitivity analysis undertaken
to assess effect of loss to follow up. Authors state that patients available
at 10-month follow up are representative
Groups balanced at baseline? Low risk “There was no difference between training (n =22) and control (n =27)
patients as regards baseline variables”.
Groups received same intervention? Low risk ”No change in medication allowed during study”.
AF: atrial fibrillation
CHF: chronic heart failure
CHD: coronary heart disease
DCM : dilated cardiomyopathy
HR: heart rate
HRQoL: health related quality of life
ITT: intention-to-treat analysis
LVEF: left ventricular ejection fraction
NYHA: New York Heart Association classification
RCT : randomised controlled trial
52Exercise based rehabilitation for heart failure (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adamopoulos 2001 Relevant outcomes not reported
Barrow 2008 <6 months follow up
Belardinelli 2005 <6 months follow up
Berg-Emons 2004 <6 months follow up
Briffa 2005 Not heart failure
Chang 2004 Relevant outcomes not reported
Coats 1992 <6 months follow up
Collins 2004 <6 months follow up
Corvera-Tindel 2004 <6 months follow up
Deng 2003 Relevant outcomes not reported
Dingli 2002 Relevant outcomes not reported
Erbs 2003 Relevant outcomes not reported
ExTraMATCH 2004 Meta-analysis
Franco 2006 <6 months follow up
Gary 2004 Relevant outcomes not reported
Haykowsky 2007 Meta-analysis
Inglis 2006 Exercise advice only
Jolly 2007 Protocol only
Jónsdóttir 2004 <6 months follow up
Kilavouri 1999 Relevant outcomes not reported
Kobayashi 2003 Relevant outcomes not reported
Lloyd-Williams 2002 Meta-analysis
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(Continued)
Meyer 2005 Relevant outcomes not reported
Molloy 2006 Relevant outcomes not reported
Myers 2001 Relevant outcomes not reported
Myers 2002 Relevant outcomes not reported
Myers 2007 Relevant outcomes not reported
Niebauer 2005 Relevant outcomes not reported
Niebauer 2005 (2) Relevant outcomes not reported
Oka 2000 Relevant outcomes not reported
Owen 2000 <6 months follow up
Parnell 2002 <6 months follow up
Ponikowski 2007 <6 months follow up
Pozehl 2003 <6 months follow up
Pu 2001 Relevant outcomes not reported
Sabelis 2004 Relevant outcomes not reported
Sarullo 2006 <6 months follow up
Selig 2004 <6 months follow up
Senden 2005 Relevant outcomes not reported
Smart 2004 Meta-analysis
Stewart 1998 Exercise advice only
Taylor-Piliae 2004 Meta-analysis
Tyni-Lenne 2001 <6 months follow up
van Tol 2006 Meta-analysis
Wielenga 1998 <6 months follow up
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(Continued)
Williams 2007 Relevant outcomes not reported
Wisløff 2007 <6 months follow up
Yeh 2004 <6 months follow up
Zhang 2003 <6 months follow up
Zhao 2005 Relevant outcomes not reported
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D A T A A N D A N A L Y S E S
Comparison 1. All exercise interventions versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All cause mortality up to12
month follow up
13 962 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.70, 1.51]
2 All cause mortality more than 12
months follow up
4 2658 Odds Ratio (M-H, Fixed, 95% CI) 0.88 [0.73, 1.07]
3 Hospital admission up to 12
month follow up
8 659 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.58, 1.07]
4 Hospital admission more than
12 months follow up
4 2658 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.90, 1.02]
5 Hospital admission heart failure
only
7 569 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.52, 0.99]
6 Health related quality of life -
MLWHF
6 700 Mean Difference (IV, Random, 95% CI) -10.33 [-15.89, -4.
77]
7 Health related quality of life - all
scales
10 3109 Std. Mean Difference (IV, Random, 95% CI) -0.56 [-0.82, -0.30]
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Analysis 1.1. Comparison 1 All exercise interventions versus usual care, Outcome 1 All cause mortality up
to12 month follow up.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 1 All cause mortality up to12 month follow up
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 5/85 4/94 8.8 % 1.38 [ 0.38, 4.98 ]
Dracup 2007 9/87 8/86 18.6 % 1.11 [ 0.45, 2.75 ]
Giannuzzi 2003 0/45 1/45 3.5 % 0.33 [ 0.01, 7.97 ]
Gielen 2003 0/10 0/10 Not estimable
Gottlieb 1999 1/17 1/16 2.4 % 0.94 [ 0.06, 13.82 ]
Hambrecht 1995 1/12 0/10 1.3 % 2.54 [ 0.11, 56.25 ]
Hambrecht 1998 1/10 1/10 2.3 % 1.00 [ 0.07, 13.87 ]
Hambrecht 2000 3/36 2/37 4.6 % 1.54 [ 0.27, 8.69 ]
Keteyian 1996 0/21 1/19 3.6 % 0.30 [ 0.01, 7.02 ]
Klecha 2007 0/25 0/25 Not estimable
McKelvie 2002 19/90 20/91 46.0 % 0.96 [ 0.55, 1.68 ]
Pozehl 2008 0/15 1/6 4.8 % 0.15 [ 0.01, 3.16 ]
Willenheimer 2000 3/27 2/33 4.2 % 1.83 [ 0.33, 10.19 ]
Total (95% CI) 480 482 100.0 % 1.02 [ 0.70, 1.51 ]
Total events: 42 (Treatment), 41 (Control)
Heterogeneity: Chi2 = 3.89, df = 10 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
0.002 0.1 1 10 500
Favours exercise Favours control
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Analysis 1.2. Comparison 1 All exercise interventions versus usual care, Outcome 2 All cause mortality
more than 12 months follow up.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 2 All cause mortality more than 12 months follow up
Study or subgroup Experimental Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 31/85 38/94 10.8 % 0.85 [ 0.46, 1.55 ]
Belardinelli 1999 9/50 20/49 7.8 % 0.32 [ 0.13, 0.80 ]
HF ACTION 2009 189/1159 198/1171 77.8 % 0.96 [ 0.77, 1.19 ]
Mueller 2007 9/25 12/25 3.6 % 0.61 [ 0.20, 1.89 ]
Total (95% CI) 1319 1339 100.0 % 0.88 [ 0.73, 1.07 ]
Total events: 238 (Experimental), 268 (Control)
Heterogeneity: Chi2 = 5.69, df = 3 (P = 0.13); I2 =47%
Test for overall effect: Z = 1.24 (P = 0.21)
0.01 0.1 1 10 100
Favours experimental Favours control
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Analysis 1.3. Comparison 1 All exercise interventions versus usual care, Outcome 3 Hospital admission up
to 12 month follow up.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 3 Hospital admission up to 12 month follow up
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 9/85 19/94 28.9 % 0.52 [ 0.25, 1.09 ]
Dracup 2007 35/87 37/86 59.5 % 0.94 [ 0.66, 1.33 ]
Giannuzzi 2003 2/45 1/45 1.6 % 2.00 [ 0.19, 21.28 ]
Gielen 2003 1/10 0/10 0.8 % 3.00 [ 0.14, 65.90 ]
Hambrecht 1995 0/12 1/10 2.6 % 0.28 [ 0.01, 6.25 ]
Keteyian 1996 0/21 1/19 2.5 % 0.30 [ 0.01, 7.02 ]
Klecha 2007 0/25 0/25 Not estimable
Passino 2006 0/44 2/41 4.1 % 0.19 [ 0.01, 3.78 ]
Total (95% CI) 329 330 100.0 % 0.79 [ 0.58, 1.07 ]
Total events: 47 (Experimental), 61 (Control)
Heterogeneity: Chi2 = 5.07, df = 6 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
0.005 0.1 1 10 200
Favours exercise Favours control
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Analysis 1.4. Comparison 1 All exercise interventions versus usual care, Outcome 4 Hospital admission
more than 12 months follow up.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 4 Hospital admission more than 12 months follow up
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Austin 2005 28/85 33/94 3.9 % 0.94 [ 0.62, 1.41 ]
Belardinelli 1999 5/50 14/49 1.8 % 0.35 [ 0.14, 0.90 ]
HF ACTION 2009 729/1159 760/1171 94.0 % 0.97 [ 0.91, 1.03 ]
Mueller 2007 2/25 3/25 0.4 % 0.67 [ 0.12, 3.65 ]
Total (95% CI) 1319 1339 100.0 % 0.96 [ 0.90, 1.02 ]
Total events: 764 (Treatment), 810 (Control)
Heterogeneity: Chi2 = 4.74, df = 3 (P = 0.19); I2 =37%
Test for overall effect: Z = 1.45 (P = 0.15)
0.01 0.1 1 10 100
Favours exercise Favours control
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Analysis 1.5. Comparison 1 All exercise interventions versus usual care, Outcome 5 Hospital admission
heart failure only.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 5 Hospital admission heart failure only
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Belardinelli 1999 5/50 14/49 22.5 % 0.35 [ 0.14, 0.90 ]
Dracup 2007 35/87 37/86 59.3 % 0.94 [ 0.66, 1.33 ]
Giannuzzi 2003 2/45 1/45 1.6 % 2.00 [ 0.19, 21.28 ]
Hambrecht 1995 0/12 1/10 2.6 % 0.28 [ 0.01, 6.25 ]
Mueller 2007 2/25 3/25 4.8 % 0.67 [ 0.12, 3.65 ]
Passino 2006 0/44 2/41 4.1 % 0.19 [ 0.01, 3.78 ]
Willenheimer 2000 0/23 3/27 5.1 % 0.17 [ 0.01, 3.07 ]
Total (95% CI) 286 283 100.0 % 0.72 [ 0.52, 0.99 ]
Total events: 44 (Treatment), 61 (Control)
Heterogeneity: Chi2 = 7.17, df = 6 (P = 0.31); I2 =16%
Test for overall effect: Z = 2.03 (P = 0.042)
0.005 0.1 1 10 200
Favours expercise Favours control
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Analysis 1.6. Comparison 1 All exercise interventions versus usual care, Outcome 6 Health related quality
of life - MLWHF.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 6 Health related quality of life - MLWHF
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Austin 2005 95 22.9 (14.7) 94 36.9 (21.3) 20.0 % -14.00 [ -19.22, -8.78 ]
Belardinelli 1999 48 39 (20) 46 52 (20) 16.1 % -13.00 [ -21.09, -4.91 ]
Dracup 2007 87 35.7 (23.7) 86 43.2 (26.5) 16.9 % -7.50 [ -14.99, -0.01 ]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 16.8 % -11.10 [ -18.65, -3.55 ]
McKelvie 2002 57 -3.4 (18.1) 67 -3.3 (13.9) 19.3 % -0.10 [ -5.86, 5.66 ]
Passino 2006 44 32 (26.5) 41 53 (32) 10.9 % -21.00 [ -33.54, -8.46 ]
Total (95% CI) 347 353 100.0 % -10.33 [ -15.89, -4.77 ]
Heterogeneity: Tau2 = 33.04; Chi2 = 17.49, df = 5 (P = 0.004); I2 =71%
Test for overall effect: Z = 3.64 (P = 0.00027)
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Analysis 1.7. Comparison 1 All exercise interventions versus usual care, Outcome 7 Health related quality
of life - all scales.
Review: Exercise based rehabilitation for heart failure
Comparison: 1 All exercise interventions versus usual care
Outcome: 7 Health related quality of life - all scales
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Austin 2005 95 22.9 (14.7) 94 36.9 (21.3) 13.1 % -0.76 [ -1.06, -0.47 ]
Belardinelli 1999 48 39 (20) 46 52 (20) 11.2 % -0.64 [ -1.06, -0.23 ]
Dracup 2007 87 35.7 (23.7) 86 43.2 (26.5) 13.0 % -0.30 [ -0.60, 0.00 ]
HF ACTION 2009 1159 -5.21 (13.72) 1171 -3.28 (13.97) 15.6 % -0.14 [ -0.22, -0.06 ]
Klocek 2005 (High) 14 -109 (23.5) 7 -71.7 (23.5) 4.4 % -1.52 [ -2.57, -0.48 ]
Klocek 2005 (Low) 14 -99 (23.5) 7 -71.7 (23.5) 4.8 % -1.12 [ -2.10, -0.13 ]
Koukouvou 2004 16 34.1 (13) 19 45.2 (9) 7.2 % -0.99 [ -1.69, -0.28 ]
McKelvie 2002 57 -3.4 (18.1) 67 -3.3 (13.9) 12.2 % -0.01 [ -0.36, 0.35 ]
Passino 2006 44 32 (26.5) 41 53 (32) 10.8 % -0.71 [ -1.15, -0.27 ]
Willenheimer 2000 20 -0.7 (0.8) 17 0 (1) 7.6 % -0.76 [ -1.44, -0.09 ]
Total (95% CI) 1554 1555 100.0 % -0.56 [ -0.82, -0.30 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 43.25, df = 9 (P<0.00001); I2 =79%
Test for overall effect: Z = 4.27 (P = 0.000020)
-4 -2 0 2 4
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A D D I T I O N A L T A B L E S
Table 1. Health-related quality of life
Trial
First author (year)
Follow up HRQoL measure Outcome values at fol-
low up
Mean (SD)
Control versus Exer-
cise, between-group P
value
Between-group differ-
ence
Austin (2005) 6 months MLWHF
Physical
Emotional
20.4 (12.2) vs 12.6 (9.7)
P < 0.0001*
Exercise > Control
Exercise > Control
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Table 1. Health-related quality of life (Continued)
5 years
Total
EQ-5D
MLWHF
Physical
Emotional
Total
EQ-5D
8.0 (7.1) vs 4.4 (10.4) P
< 0.01*
36.9 (24.0) vs 22.9 (17.
8) P < 0.001*
0.58 (0.19) vs 0.70 (0.
16) P < 0.0001*
19.3 (23.5) vs 18.3 (11.
2) P = 0.66*
7.6 (7.1) vs 7.4 (6.5) P =
0.88*
37.1 (24.9) vs 35.5 (21.
7) P = 0.72*
0.58 (0.22) vs 0.64 (0.
19) P = 0.12*
Exercise > Control
Exercise > Control
Exercise = Control
Exercise = Control
Exercise = Control
Exercise = Control
Bellardinelli (1999)
15 months
29 months
MLWHF
Total 52 (20) vs 39 (20) P < 0.
001
54 (22) vs 44 (21) P < 0.
001
Exercise > Control
Exercise > Control
Dracup (2007) 6 months MLWHF
Physical
Emotional
Total
19.4 (11.5) vs 16.1 (10.
0) P = 0.04*
10.5 (7.4) vs 7.8 (6.6) P
= 0.01*
43.2 (26.5) vs 35.7 (23.
7) P = 0.05
Exercise > Control
Exercise > Control
Exercise > Control
Gottlieb (1999) 6-months MLWHF
Total
MOS
PF
RL
GH
NR (NR) vs 22 (20) NR
NR (NR) vs 68 (28) NR
NR (NR) vs 50 (42) NR
NR (NR) vs 361 (224)
NR
NR
NR
NR
NR
HF-ACTION (2009) 30 months KCCQ 5.21 (95%CI 4.42 to 6.
00) vs 3.28 (2.48 to 4.
09) P < 0.001
Exercise > control
Klocek (2005) 6.5 months PGWB
Total 99.0 vs 109.0 (training
grp A) vs 71.7 (training
grp B) P < 0.01
Exercise > Control
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Table 1. Health-related quality of life (Continued)
Koukouvou 2004 6 months MLWHF
Total
Spritzer QLI
Total
34.1 (13.0) vs 45.1 (9.9)
P = 0.05*
7.1 (1.1) vs 9.1 (1.1) P <
0.0001*
Exercise > Control
Exercise > Control
McKelvie (2002) 12 months MLWHF
Total -3.3 (13.9) vs -3.4 (18.1)
P = 0.98
Exercise = Control
Passino (2006) 9.75 months MLWHF 53 (32) vs 32 (26.5) P <
0.0001*
Exercise > Control
Willenheimer (2001) 10 months PGAQoL 0 (1) 0.7 (0.9) P = 0.023 Exercise > Control
*calculated by Cochrane authors
QLI: quality of life index; MLWHF: Minnesota Living with Heart Failure questionnaire; PGAQoL: Patient’s Global Assessment of
Quality of life; PGWB: Psychological general Wellbeing index; KCCQ: Kansas City Cardiomyopathy Questionnaire
Exercise = Control: no statistically significant difference (P > 0.05) in HRQoL between exercise and control groups at follow up
Exercise > Control: statistically significant (P
<
= 0.05) higher HRQoL in exercise compared to control group at follow up
Exercise < Control: statistically significant (P
<
= 0.05) lower HRQoL in exercise versus control group at follow up
Exercise/control =: no statistically significant difference (P > 0.05) in HRQoL in exercise/control group compared to baseline
Exercise/control =+: statistically significant (P
<
= 0.05) higher HRQoL in exercise/control group compared to baseline
Exercise/control =-: statistically significant (P
<
= 0.05) lower HRQoL in exercise/control group compared to baseline
Table 2. Univariate meta-regression: all-cause mortality and HRQoL
All-Cause Mortality
P value
HRQoL
P value
Mean left ventricular ejection fraction
(%)
0.54 0.19
Mean age
(years)
0.76 0.62
Sex
(% male)
0.56 0.40
Type of rehabilitation
(exercise only versus comprehensive)
0.65 0.59
Type of exercise
(aerobic training alone or aerobic plus re-
sistance training)
0.75 0.50
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Table 2. Univariate meta-regression: all-cause mortality and HRQoL (Continued)
Exercise dose
(no. of weeks X no. number of sessions/
week X duration of sessions in hours)
0.66 0.14
Exercise setting
(hospital only, home only, both hospital
and home)
0.65 0.04
Duration of follow up
(months)
0.93 0.060.11
Publication date
(pre 2000 versus 2000 and later)
0.89 0.47
Risk of bias
Random code generation
Random code concealment
Outcome blinding
Intention-to-treat analysis
0.90
0.93
0.96
0.88
0.11
0.27
0.74
0.53
A P P E N D I C E S
Appendix 1. Search Strategies 2008
CENTRAL on The Cochrane LIbrary 2007, Issue 4
#1MeSH descriptor Myocardial Ischemia explode all trees
#2(myocard* NEAR isch*mi*)
#3isch*mi* NEAR heart
#4MeSH descriptor Coronary Artery Bypass explode all trees
#5coronary
#6MeSH descriptor Coronary Disease explode all trees
#7MeSH descriptor Myocardial Revascularization explode all trees
#8MeSH descriptor Myocardial Infarction explode all trees
#9myocard* NEAR infarct*
#10heart NEAR infarct*
#11MeSH descriptor Angina Pectoris explode all trees
#12angina
#13MeSH descriptor Heart Failure, Congestive explode all trees
#14heart and (failure or attack)
#15MeSH descriptor Heart Diseases explode all trees
#16heart and disease*
#17myocard*
#18cardiac*
#19CABG
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#20PTCA
#21stent* AND (heart or cardiac*)
#22MeSH descriptor Heart Bypass, Left explode all trees
#23MeSH descriptor Heart Bypass, Right explode all trees
#24(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR
#16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23)
#25MeSH descriptor Rehabilitation Centers, this term only
#26MeSH descriptor Exercise Therapy explode all trees
#27MeSH descriptor Sports, this term only
#28MeSH descriptor Exertion explode all trees
#29rehabilitat*
#30(physical* NEAR (fit* or train* or therap* or activit*))
#31MeSH descriptor Exercise explode all trees
#32(train*) near (strength* or aerobic or exercise*)
#33((exercise* or fitness) NEAR/3 (treatment or intervent* or program*))
#34MeSH descriptor Rehabilitation explode all trees
#35MeSH descriptor Patient Education explode all trees
#36(patient* NEAR/3 educat*)
#37((lifestyle or life-style) NEAR/3 (intervent* or program* or treatment*))
#38MeSH descriptor Self Care explode all trees
#39MeSH descriptor Ambulatory Care explode all trees
#40MeSH descriptor Psychotherapy explode all trees
#41psychotherap*
#42psycholog* NEAR intervent*
#43relax*
#44MeSH descriptor Mind-Body and Relaxation Techniques explode all trees
#45MeSH descriptor Counseling explode all trees
#46counsel*ing
#47MeSH descriptor Cognitive Therapy explode all trees
#48MeSH descriptor Behavior Therapy explode all trees
#49(behavio*r*) NEAR/4 (modif* or therap* or rehab* or change)
#50MeSH descriptor Stress, Psychological explode all trees
#51stress NEAR manage*
#52cognitive* NEAR therap*
#53MeSH descriptor Meditation explode all trees
#54meditat*
#55MeSH descriptor Anxiety, this term only
#56(manage*) NEAR (anxiety or depres*)
#57CBT
#58hypnotherap*
#59goal NEAR/3 setting
#60(psycho-educat*) or (psychoeducat*)
#61motivat* NEAR interv*
#62MeSH descriptor Psychopathology explode all trees
#63psychopathol*
#64MeSH descriptor Autogenic Training explode all trees
#65autogenic*
#66self near (manage* or care or motivat*)
#67distress*
#68psychosocial* or psycho-social
#69MeSH descriptor Health Education explode all trees
#70(nutrition or diet or health) NEAR education
#71heart manual
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#72(#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37)
#73(#38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR
#51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64 OR
#65 OR #66 OR #67 OR #68 OR #69 OR #70 OR #71)
#74(#72 OR #73)
#75(#74 AND #24)
MEDLINE DIALOG to WEEK 1 2008
1. SEARCH: MYOCARDIAL-ISCHEMIA#.DE.
2. SEARCH: MYOCARD$4 NEAR (ISCHAEMI$2 OR ISCHEMI$2)
3. SEARCH: (ISCHAEMI$2 OR ISCHEMI$2) NEAR HEART
4. SEARCH: CORONARY-ARTERY-BYPASS#.DE.
5. SEARCH: CORONARY.TI,AB.
6. SEARCH: CORONARY-DISEASE#.DE.
7. SEARCH: MYOCARDIAL-REVASCULARIZATION#.DE.
8. SEARCH: MYOCARDIAL-INFARCTION#.DE.
9. SEARCH: MYOCARD$5 NEAR INFARCT$5
10. SEARCH: HEART NEAR INFARCT$5
11. SEARCH: ANGINA-PECTORIS#.DE.
12. SEARCH: ANGINA.TI,AB.
13. SEARCH: HEART-FAILURE-CONGESTIVE#.DE.
14. SEARCH: HEART NEAR FAILURE
15. SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
16. SEARCH: HEART-DISEASES#.DE.
17. SEARCH: (HEART NEAR DISEASE$2).TI,AB.
18. SEARCH: MYOCARD$5.TI,AB.
19. SEARCH: CARDIAC$2.TI,AB.
20. SEARCH: CABG
21. SEARCH: PTCA
22. SEARCH: STENT$4 AND (HEART OR CARDIAC$4)
23. SEARCH: HEART-BYPASS-LEFT#.DE. OR HEART-BYPASS-RIGHT#.DE.
24. SEARCH: 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23
25. SEARCH: REHABILITATION-CENTERS.DE.
26. SEARCH: EXERCISE-THERAPY#.DE.
27. SEARCH: REHABILITATION.W..DE.
28. SEARCH: SPORTS#.W..DE.
29. SEARCH: EXERTION#.W..DE.
30. SEARCH: EXERCISE#.W..DE.
31. SEARCH: REHABILITAT$5.TI,AB.
32. SEARCH: PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$5 OR THERAP$5 OR ACTIVIT$5)
33. SEARCH: TRAIN$5 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)
34. SEARCH: (EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)
35. SEARCH: PATIENT-EDUCATION#.DE.
36. SEARCH: PATIENT$2 NEAR EDUCAT$4
37. SEARCH: (LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)
38. SEARCH: SELF-CARE.DE.
39. SEARCH: SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)
40. SEARCH: AMBULATORY-CARE.DE.
41. SEARCH: PSYCHOTHERAPY#.W..DE.
42. SEARCH: PSYCHOTHERAP$2.TI,AB.
43. SEARCH: PSYCHOLOG$5 NEAR INTERVENT$5
44. SEARCH: RELAX$6.TI,AB.
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45. SEARCH: RELAXATION-TECHNIQUES#.DE. OR MIND-BODY-AND-RELAXATION-TECHNIQUES#.DE.
46. SEARCH: COUNSELING#.W..DE.
47. SEARCH: (COUNSELLING OR COUNSELING).TI,AB.
48. SEARCH: COGNITIVE-THERAPY#.DE.
49. SEARCH: BEHAVIOR-THERAPY#.DE.
50. SEARCH: (BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAP$2 OR CHANGE)
51. SEARCH: STRESS-PSYCHOLOGICAL#.DE.
52. SEARCH: STRESS NEAR MANAGEMENT
53. SEARCH: COGNITIVE NEAR THERAP$2
54. SEARCH: MEDITAT$4
55. SEARCH: MEDITATION#.W..DE.
56. SEARCH: ANXIETY#.W..DE.
57. SEARCH: MANAGE$5 NEAR (ANXIETY OR DEPRES$5)
58. SEARCH: CBT.TI,AB.
59. SEARCH: HYPNOTHERAP$5
60. SEARCH: GOAL NEAR SETTING
61. SEARCH: GOAL$2 NEAR SETTING
62. SEARCH: PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
63. SEARCH: MOTIVAT$5 NEAR (INTERVENTION OR INTERV$3)
64. SEARCH: PSYCHOPATHOLOGY#.W..DE.
65. SEARCH: PSYCHOPATHOL$4.TI,AB.
66. SEARCH: PSYCHOSOCIAL$4.TI,AB.
67. SEARCH: DISTRESS$4.TI,AB.
68. SEARCH: HEALTH-EDUCATION#.DE.
69. SEARCH: HEALTH NEAR EDUCATION
70. SEARCH: HEART ADJ MANUAL
71. SEARCH: AUTOGENIC-TRAINING#.DE.
72. SEARCH: AUTOGENIC$5.TI.AB.
73. SEARCH: 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38
74. SEARCH: 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53
OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR
70 OR 71 OR 72
75. SEARCH: 15 OR 24
76. SEARCH: 73 or 74
77. SEARCH: 75 AND 76
78. SEARCH: RANDOMIZED-CONTROLLED-TRIALS#.DE.
79. SEARCH: PT=RANDOMIZED-CONTROLLED-TRIAL
80. SEARCH: PT=CONTROLLED-CLINICAL-TRIAL
81. SEARCH: CONTROLLED-CLINICAL-TRIALS#.DE.
82. SEARCH: RANDOM-ALLOCATION#.DE.
83. SEARCH: DOUBLE-BLIND-METHOD#.DE.
84. SEARCH: SINGLE-BLIND-METHOD#.DE.
85. SEARCH: (RANDOM$ OR PLACEBO$).TI,AB.
86. SEARCH: ((SINGL$3 OR DOUBL$3 OR TRIPL$3 OR TREBL$3) NEAR (BLIND$3 OR MASK$3)).TI,AB.
87. SEARCH: RESEARCH-DESIGN#.DE.
88. SEARCH: PT=CLINICAL-TRIAL#
89. SEARCH: CLINICAL-TRIALS#.DE.
90. SEARCH: (CLINIC$3 ADJ TRIAL$2).TI,AB.
91. SEARCH: 77 AND 90
92. SEARCH: (ANIMALS NOT HUMANS).SH.
93. SEARCH: 91 NOT 92
94. SEARCH: LIMIT 93 TO 2001-DATE
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EMBASE DIALOG to WEEK 1 2008
1. HEART-DISEASE#.DE.
2. (MYOCARD$4 NEAR (ISCHAEMI$2 OR ISCHEMI$2)).TI,AB.
3. ((ISCHAEMI$2 OR ISCHEMI$2) NEAR HEART).TI,AB.
4. CORONARY-ARTERY-DISEASE#.DE.
5. TRANSLUMINAL-CORONARY-ANGIOPLASTY#.DE.
6. (CORONARY NEAR (DISEASE$2 OR BYPASS$2 OR THROMBO$5 OR ANGIOPLAST$2)).TI,AB.
7. HEART-INFARCTION#.DE.
8. (MYOCARD$4 NEAR INFARCT$5).TI,AB.
9. (HEART NEAR INFARC$5).TI,AB.
10. HEART-MUSCLE-REVASCULARIZATION#.DE.
11. ANGINA-PECTORIS#.DE.
12. ANGINA.TI,AB.
13. CONGESTIVE-HEART-FAILURE#.DE.
14. (HEART NEAR FAILURE).TI,AB.
15. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
16. (HEART NEAR DISEASE$2).TI,AB.
17. CARDIAC$2.TI,AB.
18. CABG.TI,AB.
19. PTCA.TI,AB.
20. STENT$4.TI,AB. AND HEART.TI,AB.
21. EXTRACORPOREAL-CIRCULATION#.DE.
22. 16 OR 17 OR 18 OR 19 OR 20 OR 21
23. 15 OR 22
24. PSYCHOTHERAPY#.W..DE.
25. PSYCHOTHERAP$2.TI,AB.
26. PSYCHOLOG$5 NEAR INTERVENT$5
27. RELAX$6.TI,AB.
28. RELAXATION-TRAINING#.DE.
29. COUNSELING#.W..DE.
30. (COUNSELLING OR COUNSELING).TI,AB.
31. (BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAPY$2 OR CHANGE)
32. STRESS-MANAGEMENT#.DE.
33. STRESS NEAR MANAGEMENT
34. MEDITATION#.W..DE.
35. MEDITAT$5.TI,AB.
36. MANAGE$5 NEAR (ANXIETY OR DEPRES$5)
37. CBT.TI,AB.
38. HYPNOTHERAP$2.TI,AB.
39. GOAL$2 NEAR SETTING
40. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
41. MOTIVAT$5 NEAR INTERVENT$6
42. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
43. PSYCHOSOCIAL.TI,AB.
44. HEALTH-EDUCATION#.DE.
45. HEALTH NEAR EDUCATION
46. HEART ADJ MANUAL
47. AUTOGENIC-TRAINING#.DE.
48. AUTOGENIC.TI,AB.
49. REHABILITATION#.W..DE.
50. REHABILITATION-CENTER#.DE.
51. REHABIL$.TI,AB.
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52. SPORT#.W..DE.
53. KINESIOTHERAPY#.W..DE.
54. EXERCISE#.W..DE.
55. PHYSIOTHERAPY#.W..DE.
56. PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$5 OR THERAP$5 OR ACTIVIT$5)
57. TRAIN$5 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)
58. (EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)
59. AEROBIC$4 NEAR EXERCISE$4
60. (KINESIOTHERAPY OR PHYSIOTHERAPY).TI,AB.
61. PATIENT-EDUCATION#.DE.
62. PATIENT$2 NEAR EDUCAT$4
63. (LIFESTYLE OR LIFE ADJ STYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)
64. SELF-CARE#.DE.
65. SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)
66. AMBULATORY-CARE#.DE.
67. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
68. MOTIVAT$5 NEAR INTERVENT$6
69. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
70. PSYCHOSOCIAL.TI,AB.
71. HEALTH-EDUCATION#.DE.
72. HEALTH NEAR EDUCATION
73. HEART ADJ MANUAL
74. AUTOGENIC-TRAINING#.DE.
75. AUTOGENIC.TI,AB.
76. PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5
77. MOTIVAT$5 NEAR INTERVENT$6
78. PSYCHOSOCIAL-CARE#.DE. OR PSYCHOSOCIAL-REHABILITATION#.DE.
79. PSYCHOSOCIAL.TI,AB.
80. HEALTH-EDUCATION#.DE.
81. HEALTH NEAR EDUCATION
82. HEART ADJ MANUAL
83. 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or
42 or 43 or 44 or 45 or 46 or 47 or 48 or 49
84 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR
66 OR 67 OR 68 OR 69 OR 70 OR 71 OR 72 OR 73 OR 74 OR 75 OR 76 OR 77 OR 78 OR 79 OR 80 OR 81 OR 82
85. 83 OR 84
86. (RANDOM$ OR PLACEBO$).TI,AB.
87. (SINGL$4 OR DOUBLE$4 OR TRIPLE$4 OR TREBLE$4).TI,AB. AND (BLIND$4 OR MASK$4).TI,AB.
88. (CONTROLLED ADJ CLINICAL ADJ TRIAL).TI,AB.
89. RANDOMIZED-CONTROLLED-TRIAL#.DE.
90. 1 OR 2 OR 3 OR 4
91. 23 AND 85
92. 91 AND 92
93. LIMIT 92 TO 2001-2008
CINAHL DIALOG to WEEK 1 2008
1. ((MYOCARD$4 OR HEART) NEAR (ISCHAEMI$2 OR ISCHEMI$2)).TI,AB.
2. CORONARY.TI,AB.
3. ((MYOCARD$4 OR HEART) NEAR INFARC$5).TI,AB.
4. ANGINA.TI,AB.
5. (HEART NEAR FAILURE).TI,AB.
6. (HEART NEAR DISEAS$2).TI,AB.
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7. CARDIAC$2.TI,AB.
8. CABG
9. PTCA
10. STENT$4.TI,AB. AND (HEART OR CARDIAC$4).TI,AB.
11. MYOCARDIAL-ISCHEMIA#.DE.
12. MYOCARDIAL-INFARCTION#.DE.
13. CORONARY-ARTERY-BYPASS#.DE.
14. CORONARY-DISEASE#.DE.
15. CARDIAC-PATIENTS#.DE.
16. MYOCARDIAL-DISEASES#.DE.
17. MYOCARDIAL-REVASCULARIZATION#.DE.
18. HEART-DISEASES#.DE.
19. CARDIOVASCULAR-DISEASES#.DE.
20. HEART-FAILURE-CONGESTIVE#.DE.
21. ANGINA-PECTORIS#.DE.
22. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
OR 19 OR 20 OR 21
23. REHABILITATION#.W..DE.
24. SPORTS#.W..DE.
25. EXERCISE#.W..DE.
26. PHYSICAL-ACTIVITY#.DE.
27. MUSCLE-STRENGTHENING#.DE.
28. AEROBIC-EXERCISES#.DE.
29. PHYSICAL-FITNESS#.DE.
30. PATIENT-EDUCATION#.DE.
31. THERAPEUTIC-EXERCISE#.DE.
32. REHABILITAT$5.TI,AB.
33. (PHYSICAL$4 NEAR (FIT OR FITNESS OR TRAIN$4 OR THERAP$5 OR ACTIVIT$4)).TI,AB.
34. (TRAIN$4 NEAR (STRENGTH$3 OR AEROBIC OR EXERCIS$4)).TI,AB.
35. ((EXERCISE$4 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$2 OR THERAPY)).TI,AB.
36. (PATIENT$2 NEAR EDUCAT$4).TI,AB.
37. ((LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)).TI,AB.
38. SELF-CARE#.DE.
39. (SELF NEAR (MANAGE$5 OR CARE OR MOTIVAT$5)).TI,AB.
40. AMBULATORY-CARE#.DE.
41 AEROBIC.TI,AB.
42. RESISTANCE ADJ TRAIN$4
43. MUSCLE ADJ STRENGTH$5
44. AEROBIC.TI,AB.
45. RESISTANCE ADJ TRAIN$4
46. MUSCLE ADJ STRENGTH$5
47. PSYCHOTHERAPY#.W..DE.
48. PSYCHOTHERAP$2.TI,AB.
49. (PSYCHOLOG$5 NEAR INTERVENT$5).TI,AB.
50. RELAX.TI,AB.
51. RELAXATION-TECHNIQUES#.DE.
52. (COUNSELLING OR COUNSELING).TI,AB.
53. COUNSELING#.W..DE.
54. ((BEHAVIOR$4 OR BEHAVIOUR$4) NEAR (MODIFY OR MODIFICAT$4 OR THERAP$2 OR CHANGE)).TI,AB.
55. STRESS-MANAGEMENT#.DE.
56. (STRESS NEAR MANAG$5).TI,AB.
57. (COGNITIVE NEAR THERAP$2).TI,AB.
58. MEDITATION#.W..DE.
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59. MEDITAT$5.TI,AB.
60. ANXIETY#.W..DE.
61. (MANAGE$5 NEAR (ANXIETY OR DEPRESS$5)).TI,AB.
62. CBT.TI,AB.
63. HYPNOTHERAP$5.TI,AB.
64. (GOAL$2 NEAR SETTING).TI,AB.
65. (PSYCHO-EDUCAT$5 OR PSYCHOEDUCAT$5).TI,AB.
66. (MOTIVAT$5 NEAR (INTERV$3 OR INTERVENT$5)).TI,AB.
67. PSYCHOSOCIAL$4.TI,AB.
68. HEALTH-EDUCATION#.DE.
69. (HEALTH NEAR EDUCAT$5).TI,AB.
70. HEART ADJ MANUAL
71. AUTOGENIC$3.TI,AB.
72. 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR
39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46
73. 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR
63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR 70 OR 71
74. 72 OR 73
75. 22 AND 74
76. PT=CLINICAL-TRIAL
77. CLINICAL-TRIALS#.DE.
78. (RANDOM$5 OR PLACEBO$2).TI,AB.
79. (SINGL$ OR DOUBLE$ OR TRIPLE$ OR TREBLE$).TI,AB. AND (BLIND$ OR MASK$).TI,AB.
80. CONTROLLED ADJ CLINICAL ADJ TRIALS
81. 76 OR 77 OR 78 OR 79 OR 80
82. 75 AND 81
83. LIMIT 82 TO 2001-2008
PsycINFO DIALOG TO JANWEEK 1
1. SEARCH: HEART-DISORDERS#.DE.
2. SEARCH: MYOCARDIAL-INFARCTIONS.DE.
3. SEARCH: ISCHEMIA#.W..DE.
4. SEARCH: HEART-SURGERY.DE.
5. SEARCH: ANGIOPLASTY
6. SEARCH: HEART ADJ BYPASS
7. SEARCH: CORONARY.TI,AB.
8. SEARCH: (ISCHEMI$3 OR ISCHAEMI$3).TI,AB.
9. SEARCH: (MYOCARD$5 NEAR INFARCT$5).TI,AB.
10. SEARCH: (HEART NEAR (INFARC$5 OR FAILURE OR ATTACK)).TI,AB.
11. SEARCH: ANGINA.TI,AB.
12. SEARCH: (HEART NEAR DISEASE$2).TI,AB.
13. SEARCH: MYOCARD$5.TI,AB.
14. SEARCH: CARDIAC$4.TI,AB.
15. SEARCH: CABG.TI,AB.
16. SEARCH: PTCA.TI,AB.
17. SEARCH: 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16
18. SEARCH: PHYSICAL-ACTIVITY#.DE.
19. SEARCH: SPORTS#.W..DE.
20. SEARCH: PHYSICAL-EDUCATION.DE.
21. SEARCH: HEALTH-BEHAVIOR#.DE.
22. SEARCH: PHYSICAL-FITNESS.DE.
23. SEARCH: (PHYSICAL ADJ EDUCATION).TI,AB.
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24 SEARCH: EXERTION.TI,AB.
25. SEARCH: REHABILITAT$6.TI,AB.
26. SEARCH: (PHYSICAL NEAR (FIT$5 OR TRAIN$5 OR THERAP$5 OR ACTIVIT$4)).TI,AB.
27. SEARCH: (TRAIN$4 NEAR (STRENGTH$4 OR AEROBIC OR EXERCISE$2)).TI,AB.
28. SEARCH: ((EXERCISE$3 OR FITNESS) NEAR (TREATMENT OR INTERVENT$4 OR PROGRAM$4 OR
THERAP$2)).TI,AB.
29. SEARCH: (PATIENT WITH EDUCATION).TI,AB.
30. SEARCH: CLIENT-EDUCATION#.DE.
31. SEARCH: HEALTH-PROMOTION#.DE.
32. SEARCH: ((LIFESTYLE OR LIFE-STYLE) NEAR (INTERVENT$5 OR PROGRAM$2 OR TREATMENT$2)).TI,AB.
33. SEARCH: OUTPATIENT-TREATMENT#.DE.
34. SEARCH: 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32
OR 33
35. SEARCH: PSYCHOTHERAPY#.W..DE.
36 SEARCH: PSYCHOTHERAP$2.TI,AB.
37 SEARCH: TREATMENT#.W..DE.
38 SEARCH: (PSYCHOLOG$4 NEAR INTERVENT$5).TI,AB.
39 SEARCH: COUNSELING#.W..DE.
40 SEARCH: COPING-BEHAVIOR#.DE.
41 SEARCH: MEDITATION.W..DE.
42 SEARCH: AUTOGENIC-TRAINING.DE.
43 SEARCH: HEALTH-EDUCATION#.DE.
44. SEARCH: RELAX$6.TI,AB.
45. SEARCH: (COUNSELLING OR COUNSELING).TI,AB.
46. SEARCH: ((BEHAVIOURORBEHAVIOR) NEAR (MODIF$5 ORTHERAP$5ORREHABILIT$5 ORCHANGE)).TI,AB.
47. SEARCH: (STRESS NEAR MANAGE$5).TI,AB.
48. SEARCH: MEDITAT$5.TI,AB.
49. SEARCH: (MANAGE$5 NEAR (ANXIETY OR DEPRES$5)).TI,AB.
50. SEARCH: (CBT OR COGNITIV$2 NEAR THERAP$3).TI,AB.
51. SEARCH: HYPNOTHERAP$3.TI,AB.
52. SEARCH: (PSYCHO-EDUCAT$6 OR PSYCHOEDUCAT$6).TI,AB.
53. SEARCH: (MOTIVAT$5 NEAR INTERVENT$5).TI,AB.
54. SEARCH: (SELF NEAR MANAG$6).TI,AB.
55. SEARCH: AUTOGENIC$3.TI,AB.
56. SEARCH: (GOAL NEAR SETTING).TI,AB.
57. SEARCH: (HEALTH NEAR EDUCATION).TI,AB.
58. SEARCH: (HEART ADJ MANUAL).TI,AB.
59. SEARCH: 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49
OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58
60. SEARCH: 17 AND (34 OR 59)
61. SEARCH: (RANDOM$5 OR PLACEBO$5).TI,AB.
62. SEARCH: (DOUBLE$4 OR SINGLE$4 OR TRIPLE$4).TI,AB. AND (BLIND$4 OR MASK OR SHAM$4 OR
DUMMY).TI,AB.
63. SEARCH: RCT.TI,AB.
64. SEARCH: AT=TREATMENT$
65. SEARCH: 61 OR 62 OR 63 OR 64
66. SEARCH: 60 AND 66
67. SEARCH: LIMIT 66 TO YRS=2001-2008
ISI Proceedings, search date: 01/04/2008
# 7 807 #5 and #6
Databases=STP Timespan=2001-2008
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# 6 29,517 TS=(rehab* or educat*)
Databases=STP Timespan=2001-2008
# 5 52,687 #4 OR #3 OR #2 OR #1
Databases=STP Timespan=2001-2008
# 4 27,506 TS=(angina or cardiac* or PTCA or CABG)
Databases=STP Timespan=2001-2008
# 3 11,226 TS=((heart) SAME (infarct* or isch?emia or failure or attack))
Databases=STP Timespan=2001-2008
# 2 12,618 TS=((coronary* or heart*) SAME (by?pass or disease*))
Databases=STP Timespan=2001-2008
# 1 11,809 TS=((myocard*) SAME (isch?emia or infarct* or revasculari?*))
Databases=STP Timespan=2001-2008
Appendix 2. Search Strategy 2001
Cochrane Controlled Trials Regiser (2001, Issue 2)
1. HEART-FAILURE-CONGESTIVE*:ME
2. (HEART and FAILURE)
3. (CARDIAC and FAILURE)
4. ((#1 or #2) or #3)
5. REHABILITATION*:ME
6. EXERCISE*:ME
7. EXERCISE-THERAPY*:ME
8. SPORTS*:ME
9. PHYSICAL-EDUCATION-AND-TRAINING*:ME
10. EXERTION*:ME
11. REHABILITAT*
12. (PHYSICAL* near FIT)
13. (PHYSICAL* near FITNESS)
14. (PHYSICAL near TRAIN*)
15. (PHYSICAL* near ACTIVIT*)
16. (TRAIN* near STRENGTH*)
17. (TRAIN* near AEROBIC*)
18. (AEROBIC* near EXERCISE*)
19. KINESIOTHERAP*
20. (EXERCISE* near TRAIN*)
21. (((((((((((((((#5 or #6) or #7) or #8) or #9) or #10) or #11) or #12) or #13) or #14) or #15) or #16) or #17) or #18) or #19) or #
20)
22. (#4 and #21)
WH A T ’ S N E W
Last assessed as up-to-date: 30 June 2008.
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Date Event Description
4 March 2010 New citation required and conclusions have changed The original review identified eight trials that reported out-
comes which met the inclusion criteria of this review up-
date. The remaining were excluded as their follow-up was
less than 6 months or reported only exercise capacity out-
comes
The conclusions have focussed more on the impact of ex-
ercise-based cardiac rehabilitation in terms of clinical event
and HRQoL outcomes
4 March 2010 New search has been performed The search was updated to January 2008. Nineteen trials
have been included
H I S T O R Y
Protocol first published: Issue 4, 2001
Review first published: Issue 3, 2004
Date Event Description
18 May 2004 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
Edward Davies, Tiffany Moxham, Shah Ebrahim, and Rod Taylor were involved in the design of the update review. Tiffany Moxham
developed the search strategy. Study selection, data extraction, assessment of risk of bias and data analysis were undertaken by Edward
Davies and Rod Taylor. Edward Davies and Rod Taylor wrote the first draft of the review, and all co-authors contributed the various
drafts of the report.
D E C L A R A T I O N S O F I N T E R E S T
None
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Review updated with the following changes: (1) limited to RCTs of six months or more follow up, (2) excluded RCTs reporting only
exercise capacity (e.g. VO2 max), (3) limited inclusion of HRQoL to studies using validated HRQoL outcomes, and (4) included cost-
effectiveness outcomes.
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